AGREEMENT AND PLAN OF MERGER Dated as of December 20, 2006, By and Among DAVIS ACQUISITION SUB LLC, NHC/OP, L.P., NATIONAL HEALTHCARE CORPORATION, And NATIONAL HEALTH REALTY, INC.
Exhibit
2.1
AGREEMENT
AND PLAN OF MERGER
Dated
as of December 20, 2006,
By
and Among
XXXXX
ACQUISITION SUB LLC,
NHC/OP,
L.P.,
NATIONAL
HEALTHCARE CORPORATION,
And
NATIONAL
HEALTH REALTY, INC.
TABLE
OF CONTENTS
Page
ARTICLE
I
THE
MERGER
SECTION
1.01.
|
The
Merger
|
2
|
SECTION
1.02.
|
Closing
|
2
|
SECTION
1.03.
|
Effective
Time
|
3
|
SECTION
1.04.
|
Effects
of the Merger
|
3
|
SECTION
1.05.
|
Certificate
of Formation and Limited Liability Company Agreement
|
3
|
SECTION
1.06.
|
Sole
Managing Member of the Surviving Person
|
3
|
SECTION
1.07.
|
Officers
|
3
|
ARTICLE
II
EFFECT
OF
THE MERGER ON THE CAPITAL STOCK OF THE
CONSTITUENT
CORPORATIONS; EXCHANGE OF CERTIFICATES
SECTION
2.01.
|
Effect
on Stock
|
4
|
SECTION
2.02.
|
Exchange
of Certificates
|
4
|
SECTION
2.03.
|
Payment
|
8
|
ARTICLE
III
REPRESENTATIONS
AND WARRANTIES
SECTION
3.01.
|
Representations
and Warranties of the Company
|
9
|
SECTION
3.02.
|
Representations
and Warranties of NHC/OP Sub, NHC/OP and Parent
|
20
|
ARTICLE
IV
COVENANTS
RELATING TO CONDUCT OF BUSINESS
SECTION
4.01.
|
Conduct
of Business
|
26
|
SECTION
4.02.
|
No
Solicitation
|
30
|
ARTICLE
V
ADDITIONAL
AGREEMENTS
SECTION
5.01.
|
Preparation
of the Form S-4, the Joint Proxy Statement and the Schedule
13E-3
|
32
|
SECTION
5.02.
|
Stockholder
Meetings
|
33
|
SECTION
5.03.
|
Access
to Information; Confidentiality
|
34
|
SECTION
5.04.
|
Reasonable
Efforts
|
34
|
-i-
SECTION
5.05.
|
Company
Reorganization and Consolidation
|
35
|
SECTION
5.06.
|
[Intentionally
Omitted]
|
35
|
SECTION
5.07.
|
Indemnification,
Exculpation and Insurance
|
35
|
SECTION
5.08.
|
Fees
and Expenses
|
36
|
SECTION
5.09.
|
Public
Announcements
|
36
|
SECTION
5.10.
|
Affiliates
|
36
|
SECTION
5.11.
|
AMEX
Listing
|
36
|
SECTION
5.12.
|
Tax
Treatment
|
36
|
SECTION
5.13.
|
Rule
16b-3
|
36
|
ARTICLE
VI
CONDITIONS
PRECEDENT
SECTION
6.01.
|
Conditions
to Each Party’s Obligation to Effect the Merger
|
37
|
SECTION
6.02.
|
Conditions
to Obligations of NHC/OP Sub and Parent
|
37
|
SECTION
6.03.
|
Conditions
to Obligations of the Company
|
39
|
SECTION
6.04.
|
Frustration
of Closing Conditions
|
40
|
ARTICLE
VII
TERMINATION,
AMENDMENT AND WAIVER
SECTION
7.01.
|
Termination
|
40
|
SECTION
7.02.
|
Effect
of Termination
|
41
|
SECTION
7.03.
|
Amendment
|
44
|
SECTION
7.04.
|
Extension;
Waiver
|
44
|
ARTICLE
VIII
GENERAL
PROVISIONS
SECTION
8.01.
|
Nonsurvival
of Representations and Warranties
|
44
|
SECTION
8.02.
|
Notices
|
44
|
SECTION
8.03.
|
Definitions
|
45
|
SECTION
8.04.
|
Interpretation
|
47
|
SECTION
8.05.
|
Counterparts
|
48
|
SECTION
8.06.
|
Entire
Agreement; No Third-Party Beneficiaries
|
48
|
SECTION
8.07.
|
Assignment
|
48
|
SECTION
8.08.
|
Governing
Law
|
48
|
SECTION
8.09.
|
Specific
Enforcement
|
48
|
SECTION
8.10.
|
Consent
to Jurisdiction
|
49
|
SECTION
8.11.
|
Waiver
of Jury Trial
|
49
|
SECTION
8.12.
|
Severability
|
49
|
SECTION
8.13.
|
Management
Agreement
|
49
|
-ii-
AGREEMENT
AND PLAN OF MERGER
THIS
AGREEMENT AND PLAN OF MERGER
(this
“Agreement”)
is
dated as of December 20, 2006, among XXXXX ACQUISITION SUB LLC, a Delaware
limited liability company (“NHC/OP
Sub”),
NHC/OP, L.P., a Delaware limited partnership and the direct parent of NHC/OP
Sub
(“NHC/OP”),
NATIONAL HEALTHCARE CORPORATION, a Delaware corporation and the ultimate parent
of NHC/OP, (“Parent”),
and
NATIONAL HEALTH REALTY, INC., a Maryland corporation (the “Company”),
which
term shall, after the Consolidation (as defined below) refer to the Consolidated
Company.
RECITALS
WHEREAS,
NHC/OP
Sub is a wholly owned subsidiary of NHC/OP, L.P., which is a wholly owned
subsidiary of Parent;
WHEREAS,
the
Board of Directors of the Company has approved a consolidation of the Company
with its wholly-owned subsidiary NEW NHR, Inc. as the result of which a new
Maryland corporation (the “Consolidated
Company”)
shall
be formed upon the filing and acceptance for record of the Articles of
Consolidation with the Maryland State Department of Assessments and
Taxation;
WHEREAS,
the
Consolidated Company shall: (i) assume the corporate name “National Health
Realty, Inc.”; (ii) shall have as its outstanding stock only the stock of the
Company outstanding immediately prior to the effectiveness of the consolidation;
and (iii) shall succeed to the business, properties, assets and rights and
become subject to all of the obligations and liabilities of the Company,
including this Agreement (such transaction, the “Consolidation”);
WHEREAS,
the
Board of Directors of the Company by resolution has determined that all of
the
rights and obligations of the Company under this Agreement shall be inure to
and
be binding upon the Consolidated Company;
WHEREAS,
the
Board of Directors of the Company has approved a merger of the Consolidated
Company and its post-consolidation wholly-owned subsidiary, NHR-Delaware, Inc.,
with the Consolidated Company as the surviving entity, pursuant to Articles
of
Merger filed with the Maryland State Department of Assessments and Taxation
(the
“NHR-Delaware
Merger”);
WHEREAS,
in
connection with the NHR-Delaware Merger, the limited partnership units of
NHR/OP, L.P. held by AdamsMark, L.P. and National Health Corporation will be
redeemed for shares in the Consolidated Company or purchased or exchanged for
consideration of equal value (such redemption, purchase, or exchange to be
accomplished pursuant to a method to be agreed by the parties) (such redemption,
purchase or exchange collectively with the NHR-Delaware Merger, the
“Company
Reorganization”);
WHEREAS,
the
Board of Directors of the Company and the sole managing member of NHC/OP Sub
have approved and declared advisable, and the general partner of NHC/OP and
the
Board of Directors of Parent have approved, this Agreement and the merger of
Consolidated
Company
with and into NHC/OP Sub (the “Merger”),
upon
the terms and subject to the conditions set forth in this Agreement, whereby
each issued and outstanding share of common stock, par value $0.01 per share,
of
the Consolidated Company (the “Company
Common Stock”),
other
than any such shares directly owned by, NHC/OP Sub, Parent or the Company,
will
be converted into the right to receive cash and shares of Series A
Convertible Preferred Stock, par value $0.01 per share, of Parent, having the
rights and designations set forth in the Certificate of Designations attached
hereto as Exhibit A (the “Parent
Preferred Stock”);
WHEREAS,
simultaneously with the execution and delivery of this Agreement and as a
condition and inducement to the willingness of NHC/OP Sub, NHC/OP, Parent and
the Company to enter into this Agreement, Parent and certain stockholders of
Parent and the Company and certain stockholders of the Company are entering
into
a voting agreement (the “Voting
Agreement”)
pursuant to which, among other things, (i) the stockholders of Parent have
agreed to vote in favor of the establishment and issuance of the Parent
Preferred Stock (including any related amendment to the Certificate of
Incorporation of Parent) and (ii) the stockholders of the Company have
agreed to vote to adopt this Agreement and to take certain other actions in
furtherance of the Merger upon the terms and subject to the conditions set
forth
therein; and
WHEREAS,
an
affiliate of NHC/OP Sub manages the Company’s day-to-day affairs and operations,
and provides facilities and administrative services appropriate for such
management through its personnel pursuant to the Restated Advisory,
Administrative Services and Facilities Agreement (the “Management
Agreement”)
between
the Company and Tennessee Healthcare Advisors, LLC (the “Manager”);
WHEREAS,
NHC/OP
Sub, NHC/OP, Parent and the Company desire to make certain representations,
warranties, covenants and agreements in connection with the Merger and also
to
prescribe various conditions to the Merger.
NOW, THEREFORE,
in
consideration of the representations, warranties, covenants and agreements
contained in this Agreement, the parties hereto agree as follows:
ARTICLE
I
THE
MERGER
SECTION
1.01. The
Merger.
Upon the
terms and subject to the conditions set forth in this Agreement, and in
accordance with the Maryland General Corporation Law (the “MGCL”)
and the
Delaware Limited Liability Company Act (the “DLLCA”),
the
Company (or its successor by operation of law) shall be merged with and into
NHC/OP Sub at the Effective Time. At the Effective Time, the separate corporate
existence of the Company (or its successor by operation of law) shall cease
and
NHC/OP Sub shall continue as the surviving person in the Merger (the
“Surviving
Person”)
and
shall succeed to and assume all the rights and obligations of the Company and
the Consolidated Company in accordance with the MGCL and the DLLCA.
SECTION
1.02. Closing.
The
closing of the Merger (the “Closing”)
will
take place on the second Business Day after satisfaction or (to the extent
permitted by applicable law) waiver of the conditions set forth in Article
VI
(other
than those conditions that by their terms
-2-
are
to be
satisfied at the Closing, but subject to the satisfaction or waiver of those
conditions), at the offices of Xxxxxx Xxxxxxx Xxxxxx & Xxxxx, LLP, 000 Xxxxx
Xxxxxx, Xxxxx 0000, Xxxxxxxxx, Xxxxxxxxx 00000, unless another time, date or
place is agreed to by NHC/OP Sub and the Company. The date on which the Closing
occurs is referred to in this Agreement as the “Closing
Date”.
SECTION
1.03. Effective
Time.
Prior to
the Closing, NHC/OP Sub shall prepare, and on the Closing Date or as soon as
practicable after the Closing Date, the parties shall file a certificate of
merger (the “Certificate
of Merger”)
executed and acknowledged in accordance with the relevant provisions of the
MGCL
and the DLLCA and filed with the State Department of Assessment and Taxation
of
Maryland and the Secretary of State of the State of Delaware. The Merger shall
become effective at such time as the Certificate of Merger is accepted for
record by the State Department of Assessment and Taxation of Maryland and the
Secretary of State of the State of Delaware, or at such other time as NHC/OP
Sub
and the Company shall agree and specify in the Certificate of Merger, not to
exceed 30 days from the date of filing of the Certificate of Merger (the
“Effective
Time”).
SECTION
1.04. Effects
of the Merger.
The
Merger shall have the effects set forth in Section 3-114 of the MGCL and Section
18-209 of the DLLCA.
SECTION
1.05. Certificate
of Formation and Limited Liability Company Agreement.
(a) The
Certificate of Formation of NHC/OP Sub shall be the Certificate of Formation
of
the Surviving Person until thereafter changed or amended as provided therein
or
by applicable law.
(b) The
Limited Liability Company Agreement of NHC/OP Sub, as in effect immediately
prior to the Effective Time, shall be the Limited Liability Company Agreement
of
the Surviving Person until thereafter changed or amended as provided therein
or
by applicable law.
SECTION
1.06. Sole
Managing Member of the Surviving Person.
The sole
managing member of NHC/OP Sub immediately prior to the Effective Time shall
be
the sole managing member of the Surviving Person, until the earlier of their
death, resignation or removal or until their respective successors are duly
elected and qualified, as the case may be.
SECTION
1.07. Officers.
The
officers of the Company immediately prior to the Effective Time shall be the
officers of the Surviving Person, until the earlier of their resignation or
removal or until their respective successors are duly elected and qualified,
as
the case may be.
ARTICLE
II
EFFECT
OF THE MERGER ON THE CAPITAL STOCK OF THE
CONSTITUENT
CORPORATIONS; EXCHANGE OF CERTIFICATES
-3-
SECTION
2.01. Effect
on Stock.
At the
Effective Time, by virtue of the Merger and without any action on the part
of
the holder of any shares of stock of the Company, NHC/OP Sub, or
Parent:
(a) Cancellation
of NHC/OP Sub, NHC/OP or Parent-Owned Stock.
Each
share of Company Common Stock that is directly owned by NHC/OP Sub, NHC/OP
or
Parent or their respective Subsidiaries shall automatically be canceled and
shall cease to exist, and no consideration shall be delivered in exchange
therefor.
(b) Conversion
of Company Common Stock.
Except
as otherwise provided in Section
2.02(e),
each
share of Company Common Stock issued and outstanding immediately prior to the
Effective Time (other than shares to be canceled in accordance with Section
2.01(a))
shall be
converted into the right to receive that number of validly issued, fully paid
and nonassessable shares of Parent Preferred Stock equal to the Exchange Ratio
and $9.00 in cash (collectively, the “Merger
Consideration”).
The
“Exchange Ratio” is 1.0. At the Effective Time, all shares of Company Common
Stock converted into the Merger Consideration pursuant to this Article II
shall no
longer be outstanding and shall automatically be canceled and shall cease to
exist, and each holder of a certificate that immediately prior to the Effective
Time represented any such shares of Company Common Stock (a “Certificate”)
shall
cease to have any rights with respect thereto, except the right to receive
the
Merger Consideration, certain dividends or other distributions in accordance
with Section
2.02(c)
and any
cash in lieu of any fractional share of Parent Preferred Stock in accordance
with Section
2.02(e),
in each
case upon the surrender of such Certificate in accordance with Section
2.02(b)
and in
each case without interest.
(c) Anti-Dilution
Provisions.
In the
event Parent changes (or establishes a record date for changing) the number
of
shares of Parent Preferred Stock issued and outstanding prior to the Effective
Time as a result of a stock split, stock dividend, recapitalization,
subdivision, reclassification, combination, exchange of shares or similar
transaction with respect to the outstanding Parent Preferred Stock and the
date
of such change (or the record date with respect to such change) shall be prior
to the Effective Time, the per share cash amount and the Exchange Ratio shall
be
appropriately adjusted to provide the holders of shares of the Company Common
Stock with the same economic effect as contemplated by this Agreement prior
to
such event.
SECTION
2.02. Exchange
of Certificates.
(a) Exchange
Agent.
Prior to
the Effective Time, NHC/OP Sub shall designate a bank or trust company
reasonably acceptable to the Company to act as exchange agent (the “Exchange
Agent”)
for the
payment of the Merger Consideration and shall deposit with the Exchange Agent
as
of the Effective Time, for the benefit of the holders of shares of Company
Common Stock, for exchange in accordance with this Article
II,
through
the Exchange Agent, cash and non-certificated book-entry shares representing
the
shares of Parent Preferred Stock issuable pursuant to Section
2.01(b)
in
exchange for outstanding shares of Company Common Stock, and NHC/OP Sub shall
provide to the Exchange Agent, on a timely basis, as and when needed after
the
Effective Time, cash and/or non-certificated book-entry shares of Parent
Preferred Stock necessary to pay
-4-
dividends
or other distributions, if any, in accordance with Section
2.02(c)
and any
cash in lieu of any fractional shares of Parent Preferred Stock in accordance
with Section
2.02(e).
The
Exchange Agent shall invest any cash deposited by NHC/OP Sub pursuant to this
Section
2.02
as
directed by NHC/OP Sub on a daily basis; provided
that no
such investment or loss thereon shall affect the amounts payable or the timing
of the amounts payable to the stockholders of the Company pursuant to this
Article
II.
Any
interest and other income resulting from such investments shall promptly be
paid
to NHC/OP Sub upon request. Prior to the Effective Time, the Company will
deposit with the Exchange Agent cash sufficient to pay any dividends and other
distributions, if any, including the REIT Dividend.
(b) Exchange
Procedure.
As soon
as reasonably practicable after the Effective Time, NHC/OP Sub shall cause
the
Exchange Agent to mail to each holder of record of a Certificate whose shares
of
Company Common Stock were converted into the right to receive the Merger
Consideration pursuant to Section
2.01(b),
(i) a
letter of transmittal (which shall specify that delivery shall be effected,
and
risk of loss and title to the Certificates held by such person shall pass,
only
upon proper delivery of the Certificates to the Exchange Agent and shall be
in
such form and have such other reasonable and customary provisions as NHC/OP
Sub
may specify) and (ii) instructions for use in surrendering the Certificates
in
exchange for (A) the Merger Consideration, (B) any dividends or other
distributions to which holders of Certificates are entitled pursuant to
Section
2.02(c)
and (C)
cash in lieu of any fractional shares of Parent Preferred Stock to which such
holders are entitled pursuant to Section
2.02(e).
Upon
surrender of a Certificate for cancellation to the Exchange Agent, together
with
such letter of transmittal, duly completed and validly executed, and such other
documents as may reasonably be required by the Exchange Agent, the holder of
such Certificate shall be entitled to receive in exchange therefor (x) that
number of whole shares of Parent Preferred Stock (which shall be in
non-certificated book-entry form) which such holder has the right to receive
pursuant to the provisions of this Article
II
after
taking into account all the shares of Company Common Stock then held by such
holder under all such Certificates so surrendered, (y) cash in an amount equal
to $9.00 per share of Company Common Stock then held by such holder under all
such Certificates so surrendered plus any dividends or other distributions
to
which such holder is entitled pursuant to Section
2.02(c)
and (z)
cash in lieu of fractional shares of Parent Preferred Stock to which such holder
is entitled pursuant to Section
2.02(e),
and the
Certificate so surrendered shall forthwith be canceled. In the event of a
transfer of ownership of Company Common Stock that is not registered in the
transfer records of the Company, the Merger Consideration may be issued to
a
person other than the person in whose name the Certificate so surrendered is
registered if such Certificate shall be properly endorsed or otherwise be in
proper form for transfer and the person requesting such issuance shall pay
any
transfer or other Taxes required by reason of the issuance of shares of Parent
Preferred Stock to a person other than the registered holder of such Certificate
or establish to the reasonable satisfaction of NHC/OP Sub that such Tax has
been
paid or is not applicable. Until surrendered as contemplated by this
Section
2.02(b),
each
Certificate shall be deemed at any time after the Effective Time to represent
only the right to receive upon such surrender the Merger Consideration that
the
holder thereof has the right to receive pursuant to the provisions of this
Article
II,
any
dividends or distributions to which the holder of such Certificate is entitled
under Section
-5-
2.02(c)
and any
cash in lieu of any fractional share of Parent Preferred Stock to which the
holder of such Certificate is entitled under Section
2.02(e).
No
interest shall be paid or shall accrue on any cash payable upon surrender of
any
Certificate.
(c) Distributions
with Respect to Unexchanged Shares; Payment for Fractional
Shares.
No
dividends or other distributions declared or made with respect to shares of
Parent Preferred Stock with a record date after the Effective Time shall be
paid
to the holder of any unsurrendered Certificate with respect to the shares of
Parent Preferred Stock represented thereby, and no cash payment in lieu of
any
fractional share of Parent Preferred Stock shall be paid to any such holder
in
accordance with Section
2.02(e),
until
the surrender of such Certificate in accordance with this Article
II.
Subject
to Section 2.02(f),
following surrender of any such Certificate there shall be paid to the record
holder of any certificate representing whole shares of Parent Preferred Stock
issued in exchange therefor, without interest, (i) promptly after the time
of such surrender, the amount of dividends or other distributions with a record
date after the Effective Time theretofore paid with respect to such whole shares
of Parent Preferred Stock and the amount of any cash in lieu of any fractional
share of Parent Preferred Stock to which such holder is entitled in accordance
with Section
2.02(e),
and
(ii) at the appropriate payment date, the amount of dividends or other
distributions with a record date after the Effective Time but prior to such
surrender and with a payment date subsequent to such surrender payable with
respect to such whole shares of Parent Preferred Stock.
(d) No
Further Ownership Rights in Company Common Stock.
All
Merger Consideration issued upon the surrender for exchange of Certificates
in
accordance with the terms of this Article
II
shall be
deemed to have been issued (and paid) in full satisfaction of all rights
pertaining to the shares of Company Common Stock formerly represented by such
Certificates. At the close of business on the day on which the Effective Time
occurs, the stock transfer books of the Company shall be closed and there shall
be no further registration of transfers on the stock transfer books of the
Surviving Person of the shares of Company Common Stock that were outstanding
immediately prior to the Effective Time. Subject to the last sentence of
Section
2.02(f),
if,
after the Effective Time, Certificates are presented to the Surviving Person
or
the Exchange Agent for transfer or any other reason, they shall be canceled
and
exchanged as provided in this Article
II.
(e) No
Fractional Shares.
(A) No
certificates or scrip representing fractional shares of Parent Preferred Stock
shall be transferred as Merger Consideration upon the surrender for exchange
of
Certificates, no dividend or distribution of Parent shall relate to such
fractional share interests and such fractional share interests shall not entitle
the owner thereof to vote or to any rights of a stockholder of Parent. For
purposes of this Section
2.02(e),
all
fractional shares to which a single record holder of Company Common Stock would
otherwise be entitled shall be aggregated and calculations shall be rounded
to
three decimal places.
-6-
(B) Each
holder of shares of Company Common Stock exchanged pursuant to the Merger who
would otherwise have been entitled to receive a fraction of a share of Parent
Preferred Stock (after taking into account all such shares held by such holder),
shall be entitled to receive cash (without interest) in an amount, less the
amount of any withholding Taxes which may be required thereon, equal to such
fractional part of a share of Parent Preferred Stock multiplied by
$15.75.
(C) As
soon as
practicable after the determination of the amount of cash, if any, to be paid
to
holders of Certificates with respect to any fractional share interests, the
Exchange Agent shall make available such amounts, without interest, to such
holders subject to and in accordance with the terms of Section
2.02(c).
(f) Termination
of Merger Consideration Obligation.
Any
portion of the Merger Consideration which remains undistributed to the holders
of Company Common Stock for 12 months after the Effective Time shall be
delivered to NHC/OP Sub, upon demand. Any holders of Company Common Stock who
have not theretofore complied with this Article
II
shall
thereafter look only to NHC/OP Sub for the cash and shares of Parent Preferred
Stock to which they are entitled pursuant to Section
2.01(b),
any
dividends and other distributions to which they are entitled pursuant to
Section
2.02(c)
and any
cash in lieu of fractional shares of Parent Preferred Stock to which they are
entitled pursuant to Section
2.02(e).
If any
Certificate shall not have been surrendered prior to two years after the
Effective Time (or immediately prior to such earlier date on which any Merger
Consideration, any dividends and other distributions payable in accordance
with
Section
2.02(c)
or any
cash payable in lieu of fractional shares of Parent Preferred Stock pursuant
to
Section
2.02(e),
would
otherwise escheat to or become the property of any domestic or foreign (whether
national, Federal, state, provincial, local or otherwise) government or any
court, administrative, regulatory or other governmental agency, commission
or
authority or any non- governmental self-regulatory agency, commission or
authority (each a “Governmental
Entity”)),
any
such Merger Consideration, dividends or distributions in respect thereof or
such
cash shall, to the extent permitted by applicable law, become the property
of
NHC/OP Sub, free and clear of all claims or interest of any person previously
entitled thereto.
(g) No
Liability.
None of
NHC/OP Sub, NHC/OP, Parent, the Company or the Exchange Agent shall be liable
to
any person in respect of any Merger Consideration, any dividends and other
distributions thereon payable in accordance with Section
2.02(c)
or any
cash in lieu of fractional shares of Parent Preferred Stock payable in
accordance with Section
2.02(e),
in each
case delivered to a public official pursuant to any applicable abandoned
property, escheat or similar law or to NHC/OP Sub pursuant to Section 2.02(f).
(h) Lost
Certificates.
If any
Certificate shall have been lost, stolen or destroyed, upon the making of an
affidavit of that fact by the person claiming such Certificate to be lost,
stolen or destroyed and, if required by NHC/OP Sub, the posting by such person
of a bond in such reasonable amount as NHC/OP Sub may reasonably direct as
-7-
indemnity
against any claim that may be made against NHC/OP Sub, Parent, the Company
or
the Exchange Agent with respect to such Certificate, the Exchange Agent shall
deliver in exchange for such lost, stolen or destroyed Certificate the Merger
Consideration payable in cash and in the form of Parent Preferred Stock (which
shall be in non-certificated book-entry form), any unpaid dividends and other
distributions to which such holder would be entitled pursuant to Section
2.02(c)
and any
cash in lieu of fractional shares of Parent Preferred Stock to which such holder
would be entitled pursuant to Section
2.02(e),
in each
case pursuant to this Agreement.
(i) Withholding
Rights.
NHC/OP
Sub or the Exchange Agent shall be entitled to deduct and withhold from the
consideration otherwise payable pursuant to this Agreement to any holder of
shares of Company Common Stock such amounts as may be required to be deducted
and withheld with respect to the making of such payment under the Code, or
any
provision of state, local or foreign Tax law. To the extent that amounts are
so
withheld and paid over to the appropriate taxing authority by NHC/OP Sub or
the
Exchange Agent, such withheld amounts shall be treated for all purposes of
this
Agreement as having been paid to the holder of the shares of Company Common
Stock in respect of which such deduction and withholding was paid by NHC/OP
Sub
or the Exchange Agent.
(j) [Intentionally
Omitted]
(k) Company
Stock Options.
As of
the Effective Time, each holder of a Company Stock Option (a “Holder”)
will
receive, in the aggregate, an amount equal to their option consideration for
all
Company Stock Options. At the Effective Time, each Company Stock Option will
be
cancelled and extinguished, and the Holder thereof will be entitled to receive
an amount of consideration equal to (A) the product of (i) the number of shares
of Company Common Stock subject to such Company Stock Option and (ii) $24.75
less (B) the exercise price of such Company Stock Option, without interest
and
less any amounts required to be deducted and withheld under any applicable
Legal
Requirement (the “Option Value”). The option consideration payable to each
Holder shall be: (x) an amount of cash equal to the product of (1) the Option
Value and (2) .3636; (y) a number of shares of Parent Preferred Stock equal
to
the product of the Option Value and .6364 divided by $15.75 and (z) cash in
lieu
of any fractional shares resulting from the calculation in (y) above. All
payments with respect to canceled Company Stock Options shall be made by the
Exchange Agent (or such other agent reasonably acceptable to NHC/OP Sub as
the
Company shall designate prior to the Effective Time) as promptly as reasonably
practicable after the Effective Time from funds deposited by or at the direction
of the Surviving Person to pay such amounts in accordance with Section
2.02(b).
Prior
to the Effective Time, the Company will adopt such resolutions and will take
such other actions as may be reasonably required to effectuate the actions
contemplated by this Section
2.02(k),
without
paying any consideration or incurring any debts or obligations on behalf of
the
Company or the Surviving Person.
SECTION
2.03. Payment.
Promptly
after the Effective Time, the Exchange Agent shall pay the REIT Dividend to
the
Holders and those Persons who were Company Stockholders on the Record Date,
in
accordance with customary procedures for the payment of dividends.
-8-
ARTICLE
III
REPRESENTATIONS
AND WARRANTIES
SECTION
3.01. Representations
and Warranties of the Company.
Except
as set forth in the disclosure schedule delivered by the Company to NHC/OP
Sub
in connection with the execution of this Agreement (the “Company
Disclosure Schedule”),
the
Company represents and warrants to NHC/OP Sub, NHC/OP, and Parent as
follows:
(a) Organization,
Standing and Power.
Each of
the Company and its Subsidiaries (i) is duly organized, validly existing and
in
good standing under the laws of the jurisdiction in which it is organized,
(ii)
has the requisite corporate, company or partnership power and authority to
carry
on its business as now being conducted and (iii) is duly qualified or licensed
to do business and is in good standing in each jurisdiction in which the nature
of its business or the ownership, leasing or operation of its properties makes
such qualification or licensing necessary, other than where the failure to
be so
qualified or licensed or in good standing, either individually or in the
aggregate, has not had and would not reasonably be expected to have a Material
Adverse Effect on the Company. True and complete copies of the charter and
bylaws of the Company, as in effect as of the date of this Agreement, have
previously been made available by the Company to NHC/OP Sub.
(b) Subsidiaries.
Section
3.01(b)(i)
of the
Company Disclosure Schedule sets forth a true and complete list of all
Subsidiaries of the Company as of the date of this Agreement and, for each
such
Subsidiary, the state of organization. All the outstanding shares of capital
stock of, or other equity or voting interests in, each Subsidiary of the Company
have been validly issued and are fully paid and nonassessable and are owned
directly or indirectly by the Company, free and clear of all mortgages, claims,
liens, pledges, encumbrances, charges or security interests of any kind
(collectively, “Liens”)
and
free of any restriction on the right to vote, sell or otherwise dispose of
such
capital stock or other equity or voting interests. Except for the capital stock
of, or other equity or voting interests in, its Subsidiaries, and as set forth
on Section
3.01(b)(ii)
of the
Company Disclosure Schedule, the Company does not own of record or beneficially,
directly or indirectly, any capital stock or other equity or voting interest
in
any person.
(c) Capital
Structure.
As of
the date of this Agreement, the authorized capital stock of the Company consists
of 75,000,000 shares of Company Common Stock and 5,000,000 shares of preferred
stock, par value $0.01 per share (the “Company
Preferred Stock”).
As of
the close of business on November 30, 2006, (i) 9,949,463 shares of Company
Common Stock were issued and outstanding, (ii) 1,007,927 shares of Company
Common Stock were reserved and available for issuance pursuant to the 1997
Stock
Option and Appreciation Rights Plan and the 2005 Stock Option, Restricted Stock
and Appreciation Rights Plan (such plans, collectively, the “Company
Stock Plans”),
(iii)
75,000 shares of Company Common Stock were subject to outstanding options or
other rights to purchase shares of Company Common Stock granted under the
Company Stock Plans (the “Company
Stock Options”)
and
(iv) no shares of Company Preferred Stock were issued and outstanding. Except
as
set forth above, as of the close of business on November
-9-
30,
2006,
no shares of stock of, or other equity or voting interests in, the Company
or
options, warrants or other rights to acquire any such stock, securities or
interests were issued, reserved for issuance or outstanding. During the period
from November 30, 2006, to the date of this Agreement (A) there have been no
issuances by the Company or any of its Subsidiaries of shares of capital stock
of, or other equity or voting interests in, the Company or any of its
Subsidiaries, other than issuances of shares of Company Common Stock pursuant
to
the exercise of Company Stock Options outstanding on such date as required
by
their terms as in effect on the date of this Agreement, and (B) there have
been
no issuances by the Company or any of its Subsidiaries of options, warrants
or
other rights to acquire shares of capital stock of, or other equity or voting
interests in, the Company or any of its Subsidiaries. There are no outstanding
stock appreciation rights, “phantom” stock rights, performance units or other
rights (other than the Company Stock Options) that are linked to the price
of
Company Common Stock granted under the Company Stock Plans or otherwise. All
outstanding shares of Company Common Stock are, and all shares that may be
issued pursuant to the Company Stock Plans will be, when issued in accordance
with the terms thereof, duly authorized, validly issued, fully paid and
nonassessable and not subject to preemptive rights. Except as set forth above,
there are no securities, options, warrants, calls, rights, contracts or
agreements of any kind to which the Company or any of its Subsidiaries is a
party or by which the Company or any of its Subsidiaries is bound, obligating
the Company or any of its Subsidiaries to issue, deliver or sell, or cause
to be
issued, delivered or sold, additional shares of capital stock of, or other
equity or voting interests in, or securities convertible into, or exchangeable
or exercisable for, shares of capital stock of, or other equity or voting
interests in, the Company or any of its Subsidiaries or obligating the Company
or any of its Subsidiaries to issue, grant, extend or enter into any such
security, option, warrant, call, right, contract or agreement. As of the date
of
this Agreement, there are no irrevocable proxies and no voting agreements (other
than the Voting Agreement) to which the Company is a party with respect to
any
shares of the capital stock of, or other equity or voting interests in, the
Company or any of its Subsidiaries.
(d) Authority;
Noncontravention; Approvals.
(i) The
Company’s board of directors, at a meeting duly called and held, has by
unanimous vote of all the directors (A) determined that the Merger, this
Agreement, the Consolidation and Company Reorganization and the other
transactions contemplated hereby are advisable and in the best interests of
the
Company and the Company’s stockholders, (B) approved the Merger, this Agreement,
the Consolidation and Company Reorganization and the other transactions
contemplated hereby, (C) recommended that this Agreement, the Consolidation
and
the transactions contemplated hereby be approved and adopted by the Company’s
stockholders, and (D) directed that this Agreement be submitted to the
stockholders of the Company (or its successor) for the purpose of adopting
this
Agreement, subject to the consummation of the Consolidation ((A)-(D) shall
be
referred to as the “Company
Resolutions”).
The
Company has the requisite corporate power and authority to enter into this
Agreement and to consummate the transactions contemplated hereby, subject to
(1)
the receipt of the stockholder approval contemplated by Section
3.01(m),
(2) the
effectiveness of the Consolida-
-10-
tion
and
(3) adoption of the applicable Company Resolutions by the Board of Directors
of
the Consolidated Company. This Agreement and other agreements and documents
executed by the Company in connection herewith have been duly and validly
executed and delivered by the Company and constitute valid and binding
obligations of the Company, enforceable against the Company in accordance with
their respective terms, except that (x) such enforcement may be subject to
bankruptcy, insolvency, reorganization, moratorium or other similar laws or
judicial decisions now or hereafter in effect relating to creditors’ rights
generally and (y) the remedy of specific performance and injunctive relief
may
be subject to equitable defenses and to the discretion of the court before
which
any proceeding therefor may be brought.
(ii) Neither
the execution and delivery of this Agreement by the Company, nor the
consummation by the Company of the transactions contemplated hereby, nor
compliance by the Company with any of the terms or provisions hereof, will
(A)
violate any provision of the charter or bylaws of the Company, or (B) assuming
that the consents and approvals referred to in Section
3.01(d)(iii)
are duly
obtained, (I) violate any statute, code, ordinance, rule, regulation, judgment,
order, writ, decree or injunction applicable to the Company or any of its
Subsidiaries or any of their respective properties or assets or (II) violate,
conflict with, result in a breach of any provision of or the loss of any benefit
under, constitute a default (or an event that, with notice or lapse of time,
or
both, would constitute a default) under, result in the termination of or a
right
of termination or cancellation under, accelerate the performance required by,
accelerate any right or benefit provided by, or result in the creation of any
Lien upon any of the respective properties or assets of the Company or any
of
its Subsidiaries under, any of the terms, conditions or provisions of any
Material Contract of the Company, except (in the case of clause (B) above)
for
such violations, conflicts, breaches, losses, defaults, terminations,
cancellations, accelerations or Liens that, either individually or in the
aggregate, would not have a Material Adverse Effect on the Company or the
Surviving Person.
(iii) No
consent, approval, order or authorization of, or registration, declaration
or
filing with, any governmental entity or other Person is required by or with
respect to the Company or any of its Subsidiaries in connection with the
execution and delivery of this Agreement by the Company or the consummation
by
the Company of the transactions contemplated hereby, except for (A) the filing
with, and declared effectiveness by, the Securities Exchange Commission
(“SEC”)
of the
registration statement on Form S-4 to be filed by Parent in connection with
the
issuance of the Parent Preferred Stock in the Merger (as amended and
supplemented from time to time, the “Form
S-4”)
and the
Joint Proxy Statement(s)/Prospectus(es) for the Consolidation and the Merger
(the “Joint
Proxy Statement”),
(B) the Company Stockholder Approvals, (C) the filing of (I) the
Certificate of Merger with the State Department of Assessment and Taxation
in
the State of Maryland, (II) the Certificate of Merger with the Secretary of
State of the State of Delaware, (III) the Articles of Consolidation with the
State Department of Assessment and Taxation in the State of Maryland and (IV)
appropriate
-11-
documents
with the relevant authorities of other states in which the Company is qualified
to do business and such other consents, approvals, orders, authorizations,
registrations, declarations and filings as may be required under the “blue sky”
laws of various states, specified on Schedule 3.01(e), (D) the filing of a
premerger notification and report form by the Company under the
Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of 1976, as amended (the
“HSR
Act”)
or any
other applicable competition, merger control, antitrust or similar law or
regulation, (E) any notices to or filings with the AMEX in connection with
the Consolidation and the Merger, (F) the filing with the SEC of the Rule
13E-3 Transaction Statement on Schedule 13E-3, as amended and supplemented
from
time to time (the “Schedule
13E-3”)
(G) any
filings in connection with and approvals by the SEC required to cause the
Consolidated Company to be the successor of the Company pursuant to Rule
12(g)(3) of the Exchange Act and (H) such other consents, approvals,
orders, authorizations, registrations, declarations and filings the failure
of
which to be obtained or made would not be reasonably likely to have,
individually or in the aggregate, a Material Adverse Effect on the
Company.
(e) Company
SEC Documents; Undisclosed Liabilities.
(i) The
Company’s Annual Report on Form 10-K for the fiscal year ended December 31,
2005, as filed with the SEC (the “Company
2005 10-K”)
and all
other reports, registration statements, definitive proxy statements or
information statements filed or to be filed by the Company or any of its
Subsidiaries subsequent to the filing of the Company 2005 10-K under the
Securities Act or under Sections 13(a), 13(c), 14 and 15(d) of the Securities
Exchange Act in the form filed, or to be filed with the SEC (collectively,
the
“Company
SEC Documents”)
(A)
when filed (except as amended or supplemented prior to the date of this
Agreement), complied or will comply as to form in all material respects with
the
requirements of the Securities Act of 1933, as amended, and the rules and
regulations of the SEC promulgated thereunder (the “Securities
Act”),
or the
Securities Exchange Act of 1934, as amended, and the rules and regulations
of
the SEC promulgated thereunder (the “Exchange
Act”),
as the
case may be, applicable to such Company SEC Documents, and (B) none of the
Company SEC Documents when filed (except as amended or supplemented prior to
the
date of this Agreement), contained or will contain any untrue statement of
a
material fact or omitted or will omit to state a material fact required to
be
stated therein or necessary in order to make the statements therein, in light
of
the circumstances under which they were made, not misleading. The consolidated
financial statements of the Company (including the related notes and schedules
thereto) included in the Company SEC Documents comply or will comply as to
form,
as of their respective dates of filing with the SEC, in all material respects
with the applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto, have been or will be prepared
in
accordance with generally accepted accounting principles (“GAAP”)
(except, in the case of unaudited statements, as permitted by Form 10-Q of
the
SEC) applied on a consistent basis during the periods involved and, as of their
respective dates of filing with the SEC, fairly present or will fairly present
in all material respects the consolidated financial posi-
-12-
tion
of
the Company and its consolidated Subsidiaries as of the dates thereof and the
consolidated results of their operations and cash flows for the periods then
ended (subject, in the case of unaudited statements, to normal and recurring
year-end audit adjustments).
(ii) Except
as
set forth in the most recent financial statements included in the Company SEC
Documents, neither the Company nor any of its Subsidiaries has any liabilities
or obligations of any nature (whether accrued, absolute, contingent or
otherwise) which individually or in the aggregate has had or would reasonably
be
expected to have a Material Adverse Effect on the Company.
(f) Information
Supplied.
None of
the information supplied or to be supplied by the Company or any of its
Subsidiaries specifically for inclusion or incorporation by reference in
(i) the Form S-4 will, at the time the Form S-4 becomes effective under the
Securities Act, contain any untrue statement of a material fact or omit to
state
any material fact required to be stated therein or necessary to make the
statements therein not misleading, (ii) the Joint Proxy Statement will, at
the
date it is first mailed to the Company’s stockholders and Parent’s stockholders
and at the time of each Company Stockholders Meeting and the Parent Stockholders
Meeting, contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they are made,
not
misleading or (iii) the Schedule 13E-3 will, at the time the Schedule 13E-3
is
filed with the SEC, contain any untrue statement of material fact or omit to
state any material fact required to be stated therein or necessary to make
the
statements therein not misleading. The Joint Proxy Statement and Schedule 13E-3
will comply as to form in all material respects with the requirements of the
Exchange Act and the rules and regulations thereunder and the Form S-4 will
comply as to form in all material respects with the requirements of the
Securities Act and the rules and regulations thereunder. No representation
or
warranty is made by the Company with respect to statements relating to NHC/OP
Sub or Parent or any of their Subsidiaries made or incorporated by reference
in
the Joint Proxy Statement, the Form S-4 or the Schedule 13E-3 based on
information supplied by NHC/OP Sub, Parent or any of their Subsidiaries for
inclusion or incorporation by reference in the Joint Proxy Statement, the Form
S-4 or the Schedule 13E-3, as the case may be.
(g) Absence
of Certain Changes or Events.
Except
as disclosed in the Company SEC Documents filed prior to the date hereof, from
December 31, 2005 to the date of this Agreement, (i) the Company has not acted,
and has not permitted any of its Subsidiaries to act, in a manner prohibited
by
Section
4.01(a)
and (ii)
there has not been any event, change, effect or development that, individually
or in the aggregate, has had or would reasonably be expected to have a Material
Adverse Effect on the Company.
(h) Litigation.
Except
as disclosed in the Company SEC Documents filed prior to the date hereof, there
is no (i) suit, action, proceeding, claim, grievance, demand or
investigation pending or, to the Knowledge of the Company, threatened against
or
affecting the Company or any of its Subsidiaries or any of their respective
assets, properties, businesses or operations that, individually or in the
aggregate, has had or would rea-
-13-
sonably
be
expected to have a Material Adverse Effect on the Company or (ii) any judgment,
decree, injunction, rule or order of any Governmental Entity or arbitrator
outstanding against the Company or any of its Subsidiaries that, individually
or
in the aggregate, has had or would reasonably be expected to have a Material
Adverse Effect on the Company.
(i) Compliance
with Applicable Laws.
(i) Each
of
the Company and its Subsidiaries is in compliance with all statutes, laws,
ordinances, rules, regulations, judgments, writs, stipulations, orders and
decrees of any Governmental Entity applicable to it or its business or
operations (collectively, “Legal
Provisions”),
except
for instances of noncompliance or possible noncompliance that, individually
or
in the aggregate, have not had and would not reasonably be expected to have
a
Material Adverse Effect on the Company. Each of the Company and its Subsidiaries
has in effect all approvals, authorizations, certificates, filings, franchises,
licenses, notices and permits of or with all Governmental Entities, promulgated
under any Legal Provisions (collectively, “Permits”),
necessary for it to own, lease or operate its properties and other assets and
to
carry on its business and operations as presently conducted and as currently
proposed by its management to be conducted, except where the failure to so
have
in effect, individually or in the aggregate, has not had and would not
reasonably be expected to have a Material Adverse Effect on the Company. There
has occurred no default under, or violation of, any such Permit, except
individually or in the aggregate, as has not had and would not reasonably be
expected to have a Material Adverse Effect on the Company. The consummation
of
the Merger and the other transactions contemplated by this Agreement and the
Voting Agreement, in and of themselves, would not cause the revocation or
cancellation of any such Permit that, individually or in the aggregate, would
reasonably be expected to have a Material Adverse Effect on the
Company.
(ii) Except
for
those matters disclosed in the Company SEC Documents filed prior to the date
hereof and those matters that, individually or in the aggregate, would not
reasonably be expected to have a Material Adverse Effect on the
Company:
(A) the
Company and each of its Subsidiaries are and have been in compliance with all
applicable Environmental Laws, and neither the Company nor any of its
Subsidiaries has received any (1) written communication that alleges that the
Company or any of its Subsidiaries is in violation of, or has liability under,
any Environmental Law, (2) written request from any Governmental Entity for
information pursuant to any Environmental Law, or (3) written notice regarding
any requirement proposed for adoption or implementation by any Governmental
Entity under any Environmental Law which requirement is applicable to the
operations of the Company or any of its Subsidiaries;
-14-
(B) there
are
no Environmental Claims pending or, to the Knowledge of the Company, threatened,
against the Company or any of its Subsidiaries;
(C) to
the
Knowledge of the Company, there have been no Releases of any Hazardous Material
at the Company’s real property that could be reasonably expected to form the
basis of any Environmental Claim against the Company or any of its Subsidiaries;
and
(D) (1) neither
the Company nor any of its Subsidiaries has retained or assumed, either
contractually or by operation of law, any liabilities or obligations that could
be reasonably expected to form the basis of any Environmental Claim against
the
Company or any of its Subsidiaries, and (2) to the Knowledge of the Company,
there are no Environmental Claims against any person whose liabilities for
such
Environmental Claims the Company or any of its Subsidiaries has or may have
retained or assumed either contractually or by operation of law.
(iii) (A) “Environmental
Claim”
means
any and all administrative, regulatory or judicial actions, suits, orders,
demands, directives, claims, liens, investigations, proceedings or written
notices of noncompliance or violation by or from any person alleging liability
of whatever kind or nature (including liability or responsibility for the costs
of enforcement proceedings, investigations, cleanup, governmental response,
removal or remediation, natural resources damages, property damages, personal
injuries, medical monitoring, penalties, contribution, indemnification and
injunctive relief) arising out of, based on or resulting from (1) the presence
or Release of, or exposure to, any Hazardous Materials; or (2) the failure
to
comply with any Environmental Law.
(B) “Environmental
Laws”
means
all applicable federal, state, and local laws, rules, regulations, orders,
decrees, judgments, legally binding agreements or permits issued, promulgated
or
entered into by or with any Governmental Entity, pursuant to any Environmental
Law and relating to pollution, natural resources or protection of endangered
or
threatened species, health, safety or the environment (including ambient air,
surface water, groundwater, land surface or subsurface strata).
(C) “Hazardous
Materials”
means
any petroleum or petroleum products, radioactive materials or wastes, asbestos
in any form, and polychlorinated biphenyls, and any other chemical, material,
substance or waste regulated as a hazardous substance, hazardous waste, or
other
similar term under any applicable Environmental Law.
(D) “Release”
means
any release, spill, emission, leaking, dumping, injection, pouring, deposit,
disposal, or discharge into the environment (including ambient air, surface
water, groundwater, land surface or subsurface strata) or within any building,
structure, facility or fixture.
-15-
(j) Contracts.
Except
as filed as exhibits to the Company SEC Documents prior to the date of this
Agreement, neither the Company nor its Subsidiaries are bound by any contract,
arrangement, commitment or understanding (whether written or oral) that (i)
is a
“material contract” (as such term is defined in Item 601(b)(10) of Regulation
S-K promulgated by the SEC) or (ii) materially limits or otherwise
materially restricts the Company or any of its Subsidiaries or would, after
the
Effective Time, materially limit the Surviving Person or any successor thereto,
from engaging or competing in any material line of business. Each contract,
arrangement, commitment or understanding (whether written or oral) described
above in this Section
3.01(j)
is
referred to in this Agreement as a “Material
Contract”.
Neither
the Company nor any of its Subsidiaries has Knowledge, or has received notice,
of any violation of or default under a Material Contract, except for violations
that would not have a Material Adverse Effect on the Company.
(k) No
Excess Parachute Payments.
There is
no amount or other entitlement or economic benefit that could reasonably be
expected to be received (whether in cash or property or the vesting of property)
as a result of the execution and delivery of this Agreement, the obtaining
of
the Company Stockholder Approvals or the Parent Stockholder Approval, the
consummation of the Merger or any other transaction contemplated by this
Agreement or the Voting Agreement (including as a result of termination of
employment on or following the Effective Time) by or for the benefit of any
director, officer or consultant of the Company or any of its Affiliates who
is a
“disqualified individual” (as such term is defined in proposed Treasury
Regulation Section 1.280G-1) under any Company Benefit Plan, Company Benefit
Agreement or otherwise would be an “excess parachute payment” (as such term is
defined in Section 280G(b)(1) of the Code), and no disqualified individual
is
entitled to receive any additional payment from the Company or any of its
Subsidiaries, the Surviving Person or any other person in the event that the
excise Tax required by Section 4999 (a) of the Code is imposed on such
disqualified individual (a “Parachute
Gross Up Payment”).
(l) Taxes.
(i) The
Company has filed or has caused to be filed all Tax Returns required to be
filed
by it and all such Tax Returns are complete and accurate in all respects, except
for failures to file Tax Returns, or omissions or inaccuracies in any Tax
Returns, that would not result in a Material Adverse Effect with respect to
the
Company. The Company has paid or caused to be paid all Taxes due and owing,
and
the most recent financial statements contained in the Company SEC Documents
filed prior to the date hereof reflect an adequate reserve (excluding any
reserves for deferred Taxes) for all Taxes payable by the Company for all
taxable periods and portions thereof accrued through the date of such financial
statements, except for failures to pay Taxes or to reflect adequate reserves
that would not result in a Material Adverse Effect with respect to the
Company.
(ii) No
deficiencies, audit examinations, refund litigation, proposed adjustments or
matters in controversy for any Taxes have been proposed, asserted or assessed
in
writing against the Company, except for any such deficiencies, examinations,
litigation, adjustments or matters that have been resolved with the
ap-
-16-
plicable
Tax authority or that would not result in a Material Adverse Effect with respect
to the Company. There is no currently effective agreement or other document
extending, or having the effect of extending, the period of assessment or
collection of any material Taxes of the Company.
(iii) The
Company has not constituted either a “distributing corporation” or a “controlled
corporation” in a distribution of stock qualifying for tax-free treatment under
Section 355 of the Code in the two years prior to the date of this
Agreement.
(iv) The
Company has complied in all respects with all applicable statutes, laws,
ordinances, rules and regulations relating to the withholding of Taxes
(including withholding of Taxes pursuant to Sections 1441, 1442, 3121 and 3402
of the Code and similar provisions under any Federal, state, local or foreign
Tax laws) and has, within the time and the manner prescribed by law, withheld
from and paid over to the proper Governmental Entity all amounts required to
be
so withheld and paid over under applicable laws, except, in each case, for
any
failures that would not result in a Material Adverse Effect with respect to
the
Company.
(v) As
used in
this Agreement, “Taxes”
shall
include all domestic or foreign (whether national, federal, state, provincial,
local or otherwise) income, property, sales, excise, withholding and other
taxes
and similar governmental charges, including any interest, penalties and
additions with respect thereto, and “Tax
Returns”
shall
mean any return, declaration, report, claim for refund, or information return
or
statement required to be filed with any Governmental Entity with respect to
Taxes, including any schedule or attachment thereto, and including any amendment
thereof.
(m) Stockholder
Approval.
The
affirmative votes of the holders of at least a majority of the issued and
outstanding shares of Company Common Stock are the only votes of the Company’s
stockholders required to approve the Consolidation and the Merger under
applicable Legal Provisions and the organizational documents of the Company,
NHR
Sub and NHR-Delaware, Inc.
(n) State
Takeover Statutes.
The
Board of Directors of the Company has approved and declared advisable the terms
of this Agreement and the consummation of this Agreement, the Consolidation
and
the Company Reorganization and the other transactions contemplated by this
Agreement and has approved the Voting Agreement. Assuming stockholder approval
of the Consolidation and the filing and acceptance for record of the Articles
of
Consolidation, this Agreement, the Voting Agreement, the Merger, the
Consolidation, the Company Reorganization and the other transactions
contemplated by this Agreement or by the Voting Agreement will not be subject
to
the provisions of Title 3, Subtitle 6 of the MGCL. To the Knowledge of the
Company, no other state takeover statute or similar statute or regulation or
similar provision of the Company’s Charter applies or purports to apply to this
Agreement, the Voting Agreement, the Merger, the Con-
-17-
solidation,
the Company Reorganization or the other transactions contemplated by this
Agreement or by the Voting Agreement.
(o) Brokers.
No
broker, investment banker, financial advisor or other person, other than 2nd
Generation Capital, LLC, the fees, commissions and expenses of which will be
paid by the Company pursuant to an agreement, a true and complete copy of which
has been delivered to NHC/OP Sub, is entitled to any broker’s, finder’s,
financial advisor’s or other similar fee or commission, or the reimbursement of
expenses, in connection with the transactions contemplated by this Agreement
or
the Voting Agreement based upon arrangements made by or on behalf of the Company
or any of its Subsidiaries.
(p) Opinion
of Financial Advisor.
The
Special Committee has received the opinion of 2nd Generation Capital, LLC,
dated
the date of this Agreement, to the effect that, as of such date, the Merger
Consideration is fair from a financial point of view to the stockholders of
the
Company, a signed copy of which opinion has been delivered to NHC/OP
Sub.
(q) Real
Estate Matters.
(i) Unless
otherwise disclosed on Section
3.01(q)(i)
of the
Company Disclosure Schedule, the Company or its Subsidiaries own the real
properties (including all improvements thereon) listed in Section
3.01(q)(i)
of the
Company Disclosure Schedule (the “Company
Owned Real Property”).
With
respect to the Company Owned Real Property:
(A) The
Company or its Subsidiaries own and hold good and marketable fee simple title
to
each Company Owned Real Property free and clear of all liens, claims, mortgages
and encumbrances except for Permitted Exceptions. For purposes of this
Agreement, “Permitted
Exceptions”
shall
mean: (i) liens for taxes and assessments assessed by state or local
jurisdictions not yet due and payable; (ii) imperfections of title,
covenants, agreements, conditions, restrictions, reservations, easements, rights
of way and other exceptions of record, if any, which do not materially adversely
affect the present use of the Company Owned Real Property or the marketability
thereof, or otherwise materially interfere with the business being conducted
on
the Company Owned Real Property; (iii) any statutory lien arising in the
ordinary course of business by operation of law with respect to a liability
that
is not yet due or delinquent; (iv) liens for taxes, assessments and charges
and other claims which the Company is contesting in good faith; (v) all
zoning and building laws, ordinances, resolutions and regulations; (vi) the
Company Leases (as defined in Section
3.01(q)(ii))
and any
liens, claims or encumbrances created by or arising from acts or omissions
of
lessees thereunder and (vii) any matters disclosed in the title insurance
policies relating to the Company Owned Real Property; provided
that a
true and complete copy of such title insurance policies have been delivered
to
NHC/OP Sub.
-18-
(B) With
respect to the Company Owned Real Property, there are no outstanding contracts
for the sale of any Company Owned Real Property, except as set forth on in
Section
3.01(q)(ii)
of the
Company Disclosure Schedule.
(C) Neither
the whole nor any portion of the Company Owned Real Property has been condemned,
requisitioned or otherwise taken by any public authority (a “Public
Taking”),
and no
written notice of any Public Taking has been received by the Company with regard
to any Company Owned Real Property. The Company has no Knowledge that any such
Public Taking is threatened or contemplated. The Company has no Knowledge of
any
public improvements which have been ordered to be made and/or which have not
heretofore been assessed, and the Company has no Knowledge of any special,
general or other assessments pending, threatened against or affecting any
Company Owned Real Property.
(ii) The
Company or its Subsidiaries lease, as lessor, all of the real properties
(including all improvements thereon) listed in Section
3.01(q)(ii)
of the
Company Disclosure Schedule (the “Company
Leases”).
(iii) The
Company or its Subsidiaries are the sole payees and mortgagees of the promissory
notes listed in Section
3.01(q)(iii)
of the
Company Disclosure Schedule.
(iv) The
Company or its Subsidiaries are the mortgagors of the mortgages listed in
Section
3.01(q)(iv)
of the
Company Disclosure Schedule.
(v) There
are
no liens, filed or otherwise claimed, in connection with any work, labor and/or
materials performed on or furnished in connection with the Company Owned Real
Property prior to the Closing.
(r) Section 3.01(r)
of the
Company Disclosure Schedule sets forth a true and complete list of each Company
Benefit Plan and each Company Benefit Agreement. Neither the Company, any of
its
Subsidiaries nor any entity treated as a single employer with the Company or
any
of its Subsidiaries under Section 414(b), (c), (m) or (o) of the
Code maintains, is required to contribute to, or otherwise has any liability,
whether contingent or otherwise, with respect to any “employee benefit plan”
(within the meaning of Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended (“ERISA”) that (i) is a “multiemployer plan” as
defined in Sections 3(37) of ERISA, (ii) is subject to
Section 412 of the Code or Title IV of ERISA, (iii) provides for
post-retirement medical, life insurance or other welfare-type benefits (other
than as required by Part 6 of Subtitle B of Title I of ERISA or
Section 4980B of the Code or under a similar state law), or (iv) is a
“defined benefit plan” (as defined in Section 414 of the Code), whether or
not subject to the Code or ERISA. The Company Benefit Plans have been maintained
and administered in all material respects in accordance with their terms and
applicable Legal Requirements.
-19-
SECTION
3.02. Representations
and Warranties of NHC/OP Sub, NHC/OP and Parent.
Except
as set forth in the disclosure schedule delivered by NHC/OP Sub to the Company
in connection with the execution of this Agreement (the “NHC/OP
Sub Disclosure Schedule”),
NHC/OP
Sub, NHC/OP, and Parent represent and warrant to the Company as
follows:
(a) Organization,
Standing and Power.
Each of
NHC/OP Sub, NHC/OP and Parent (i) is duly organized, validly existing and in
good standing under the laws of the jurisdiction in which it is organized,
(ii) has the requisite organizational power and authority to carry on its
business as now being conducted and (iii) is duly qualified or licensed to
do
business and is in good standing in each jurisdiction in which the nature of
its
business or the ownership, leasing or operation of its properties makes such
qualification or licensing necessary, other than where the failure to be so
qualified or licensed or in good standing, individually or in the aggregate,
would not reasonably be expected to have a Material Adverse Effect on NHC/OP
Sub, NHC/OP or Parent. True and complete copies of the organizational documents
of NHC/OP Sub, NHC/OP and Parent, as in effect as of the date of this Agreement,
have previously been made available by NHC/OP Sub, NHC/OP and Parent to the
Company.
(b) Subsidiaries.
Section
3.02(b)(i)
of the
NHC/OP Sub Disclosure Schedule sets forth a true and complete list of all
Subsidiaries of Parent as of the date of this Agreement and, for each such
Subsidiary, the state of organization. All the outstanding shares of capital
stock of, or other equity or voting interests in, each Subsidiary of Parent
have
been validly issued and are fully paid and nonassessable and are owned directly
or indirectly by Parent, free and clear of all Liens and free of any restriction
on the right to vote, sell or otherwise dispose of such capital stock or other
equity or voting interests. Except for the capital stock of, or other equity
or
voting interests in, its Subsidiaries, and as set forth on Section
3.02(b)(ii)
of the
NHC/OP Sub Disclosure Schedule, Parent does not own, of record or beneficially,
directly or indirectly, any capital stock or other equity or voting interest
in
any person.
(c) Capital
Structure.
As of
the date of this Agreement, the authorized capital stock of Parent consists
of
30,000,000 shares of common stock, par value $0.01 per share (the “Parent
Common Stock”)
and
10,000,000 shares of preferred stock, par value $0.01 per share (the
“Previously
Authorized Parent Preferred Stock”).
As of
the close of business on November 30, 2006, (i) 12,307,596 shares of Parent
Common Stock were issued and outstanding, (ii) no shares of Previously
Authorized Parent Preferred Stock were issued and outstanding,
(iii) 1,111,548 shares of Parent Common Stock were reserved for issuance
pursuant to the Employee Stock Purchase Plan, the 1997 Stock Option Plan, the
2004 Non-qualified Stock Option Plan, and the 2005 Stock Option Employee Stock
Purchase, Physician Stock Purchase and Stock Appreciation Rights Plan (such
plans, collectively, the “Parent
Stock Plans”)
and
(iv) 1,471,000 shares of Parent Common Stock were subject to outstanding options
or other rights to purchase shares of Parent Common Stock granted under the
Parent Stock Plans (the “Parent
Stock Options”).
Except
as set forth above, as of the close of business on November 30, 2006, no shares
of capital stock of, or other equity or voting interests in, Parent or options,
warrants or other rights to acquire any such stock, securities or interests
were
issued, reserved for issuance or outstanding. During the period November 30,
2006, to the date of this Agreement (A) there have been
-20-
no
issuances by Parent or any of its Subsidiaries of shares of capital stock of,
or
other equity or voting interests in, Parent other than issuances of shares
of
Parent Common Stock pursuant to the exercise of Parent Stock Options outstanding
on such date as required by their terms as in effect on the date of this
Agreement, and (B) there have been no issuances by Parent or any of its
Subsidiaries of options, warrants or other rights to acquire shares of capital
stock of, or other equity or voting interests in, Parent. All outstanding shares
of Parent Common Stock are, and all shares that may be issued pursuant to the
Parent Stock Plans or upon conversion of the Parent Preferred Stock will be,
when issued in accordance with the terms thereof, duly authorized, validly
issued, fully paid and nonassessable and not subject to preemptive rights.
As of
the date of this Agreement, there are no bonds, debentures, notes or other
indebtedness of Parent or any of its Subsidiaries, and, except as set forth
above, no securities or other instruments or obligations of Parent or any of
its
Subsidiaries the value of which is in any way based upon or derived from any
capital or voting stock of Parent, in each case having the right to vote (or
convertible into, or exchangeable for, securities having the right to vote)
on
any matters on which stockholders of Parent or any of its Subsidiaries may
vote.
Except as set forth above or as otherwise contemplated herein there are no
securities, options, warrants, calls, rights, contracts or agreements of any
kind to which Parent or any of its Subsidiaries is a party or by which Parent
or
any of its Subsidiaries is bound, obligating Parent or any of its Subsidiaries
to issue, deliver or sell, or cause to be issued delivered or sold, additional
shares of capital stock of, or other equity or voting interests in, or
securities convertible into, or exchangeable or exercisable for, shares of
capital stock of, or other equity or voting interests in, Parent or any of
its
Subsidiaries or obligating Parent or any of its Subsidiaries to issue, grant,
extend or enter into any such security, option, warrant, call, right, contract
or agreement. As of the date of this Agreement, there are no irrevocable proxies
and no voting agreements (other than the Voting Agreement) to which Parent
is a
party with respect to any shares of the capital stock of, or other equity or
voting interests in, Parent or any of its Subsidiaries.
The
authorized limited liability membership interests of NHC/OP Sub are duly
authorized, validly issued and held of record by NHC/OP. The partnership
interests of NHC/OP are duly authorized and held of record by Parent and
NHC-Delaware, Inc.
(d) Authority;
Noncontravention.
The
general partner of NHC/OP, the sole managing member of NHC/OP Sub and the Board
of Directors of Parent have approved the Merger and this Agreement. Each of
NHC/OP Sub, NHC/OP and Parent has the requisite organizational power and
authority to enter into this Agreement and to consummate the transactions
contemplated hereby. The execution and delivery of this Agreement by NHC/OP
Sub,
NHC/OP and Parent, and the consummation by NHC/OP Sub, NHC/OP and Parent of
the
transactions contemplated hereby have been duly authorized by all necessary
organizational action on the part of NHC/OP Sub, NHC/OP and Parent, subject
to
approval by Parent’s stockholders. This Agreement and other agreements and
documents executed by NHC/OP Sub, NHC/OP and Parent and their respective
Affiliates in connection herewith have been duly and validly executed and
delivered by NHC/OP Sub, NHC/OP and Parent, respectively, and constitute valid
and binding obligations of NHC/OP Sub, NHC/OP and Parent, respectively,
enforceable against NHC/OP, NHC/OP Sub and Parent in accordance with their
respective terms, except that (x) such enforce-
-21-
ment
may
be subject to bankruptcy, insolvency, reorganization, moratorium or other
similar laws or judicial decisions now or hereafter in effect relating to
creditors’ rights generally, and (y) the remedy of specific performance and
injunctive relief may be subject to equitable defenses and to the discretion
of
the court before which any proceeding therefor may be brought. No consent,
approval, order or authorization of, or registration, declaration or filing
with, any governmental entity or other Person is required by or with respect
to
NHC/OP Sub, NHC/OP, Parent or any of their respective Subsidiaries in connection
with the execution and delivery of this Agreement by NHC/OP Sub, NHC/OP and
Parent or the consummation by NHC/OP Sub, NHC/OP and Parent of the transactions
contemplated hereby, except for (i) the filing with, and declared
effectiveness by, the SEC of the Form S-4 and the Joint Proxy Statement, (ii)
consents, authorizations, approvals, filings or exemptions in connection with
the rules of the AMEX, (iii) the Parent Stockholder Approval, (v) the filing
of
(A) the amendment to Parent’s Certificate of Incorporation with respect to the
Parent Preferred Stock, (B) the Articles of Merger with the Secretary of State
of the State of Delaware, and (C) the Articles of Merger with the State
Department of Assessment and Taxation in the State of Maryland and appropriate
documents with the relevant authorities of other states in which Parent is
qualified to do business and such other consents, approvals, orders,
authorizations, registrations, declarations and filings as may be required
under
the “takeover” or “blue sky” laws of various states, (vi) the filing of a
premerger notification and report form by Parent under the HSR Act or any other
applicable competition, merger control, antitrust or similar law or regulation,
(vii) the filing with the SEC of the Schedule 13E-3 and (viii) such other
consents, approvals, orders, authorizations, registrations, declarations and
filings the failure of which to be obtained or made would not be reasonably
likely to have, individually or in the aggregate, a Material Adverse Effect
on
NHC/OP Sub, NHC/OP or Parent.
(e) Parent
SEC Documents.
Parent
has filed with the SEC all reports, schedules, forms, statements and other
documents (including exhibits and all other information incorporated therein)
required to be filed by Parent since January 1, 2006 (collectively,
“Parent
SEC Documents”).
As of
their respective dates, the Parent SEC Documents complied as to form in all
material respects with the requirements of the Securities Act or the Exchange
Act, as the case may be, and the rules and regulations of the SEC promulgated
thereunder applicable to such Parent SEC Documents, and none of the Parent
SEC
Documents when filed contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary
in
order to make the statements therein, in light of the circumstances under which
they were made, not misleading. Except to the extent that information contained
in any Parent SEC Document filed and publicly available prior to the date of
this Agreement has been revised or superseded by a later filed Parent SEC
Document, none of the Parent SEC Documents contains any untrue statement of
a
material fact or omits to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The consolidated
financial statements (including the related notes) of Parent included in the
Parent SEC Documents comply as to form, as of their respective dates of filing
with the SEC, in all material respects with the applicable accounting
requirements and the published rules and regulations of the SEC with respect
thereto, have been prepared in accordance with GAAP (except, in the case of
unaudited statements, as permitted by Form 10-Q of the SEC) applied on a
consistent basis during
-22-
the
periods involved (except as may be indicated in the related notes) and fairly
present in all material respects the consolidated financial position of Parent
and its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject,
in the case of unaudited statements, to normal recurring year-end audit
adjustments). Except as set forth in the most recent financial statements
included in the Parent SEC Documents, neither Parent nor any of its Subsidiaries
has any liabilities or obligations of any nature (whether accrued, absolute,
contingent or otherwise) which individually or in the aggregate would reasonably
be expected to have a Material Adverse Effect on Parent.
(f) Information
Supplied.
None of
the information supplied or to be supplied by NHC/OP Sub or Parent specifically
for inclusion or incorporation by reference in (i) the Form S-4 will, at the
time the Form S-4 becomes effective under the Securities Act, contain any untrue
statement of a material fact or omit to state any material fact required to
be
stated therein or necessary to make the statements therein not misleading,
(ii)
the Joint Proxy Statement will, at the date it is first mailed to each of the
Company’s stockholders and Parent’s stockholders and at the time of each of the
Company Stockholders Meeting and the Parent Stockholders Meeting, contain any
untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements therein not
misleading or (iii) the Schedule 13E-3 will, at the time the Schedule 13E-3
is
filed with the SEC, contain any untrue statement of material fact or omit to
state any material fact required to be stated therein or necessary to make
the
statements therein not misleading. The Joint Proxy Statement and Schedule 13E-3
will comply as to form in all material respects with the requirements of the
Exchange Act and the rules and regulations thereunder and the Form S-4 will
comply as to form in all material respects with the requirements of the
Securities Act and the rules and regulations thereunder. No representation
or
warranty is made by NHC/OP Sub or Parent with respect to statements relating
to
the Company or any of its Subsidiaries made or incorporated by reference in
the
Joint Proxy Statement, the Form S-4 or the Schedule 13E-3 based on information
supplied by the Company or any of its Subsidiaries for inclusion or
incorporation by reference in the Joint Proxy Statement, the Form S-4 or the
Schedule 13E-3, as the case may be.
(g) Absence
of Certain Changes or Events.
Except
as disclosed in the Parent SEC Documents, from December 31, 2005, to the date
of
this Agreement, (i) Parent has not acted, and has not permitted any of its
Subsidiaries to act, in a manner prohibited by Section
4.01(b)
and (ii)
there has not been any event, change, effect or development that, individually
or in the aggregate, has had or would reasonably be expected to have a Material
Adverse Effect on Parent.
(h) Litigation.
Except
as disclosed in the Parent SEC Documents, there is no suit, action, proceeding,
claim, grievance, demand or investigation pending or, to the Knowledge of
Parent, threatened against or affecting the Parent or any of its Subsidiaries
or
any of their respective assets, properties, businesses or operations that,
individually or in the aggregate, has had or would reasonably be expected to
have a Material Adverse Effect on Parent.
-23-
(i) Compliance
with Applicable Laws.
(i) Each
of
Parent and its Subsidiaries is in compliance with all Legal Provisions, except
for instances of noncompliance or possible noncompliance that, individually
or
in the aggregate, have not had and would not reasonably be expected to have
a
Material Adverse Effect on Parent. Each of Parent and its Subsidiaries has
in
effect all material Permits necessary for it to own, lease or operate its
properties and other assets and to carry on its business and operations as
presently conducted and as currently proposed by its management to be conducted,
except where the failure to so have in effect, individually or in the aggregate,
has not had and would not reasonably be expected to have a Material Adverse
Effect on Parent. There has occurred no default under, or violation of, any
such
Permit, except, individually or in the aggregate, as has not had and would
not
reasonably be expected to have a Material Adverse Effect on Parent. The
consummation of the Merger and the other transactions contemplated by this
Agreement and the Voting Agreement, in and of themselves, would not cause the
revocation or cancellation of any such Permit that, individually or in the
aggregate, would reasonably be expected to have a Material Adverse Effect on
Parent.
(ii) Except
for
those matters disclosed in Parent SEC Documents and those matters that,
individually or in the aggregate, would not reasonably be expected to have
a
Material Adverse Effect on Parent:
(A) Parent
and
each of its Subsidiaries are in compliance with all applicable Environmental
Laws, and neither Parent nor any of its Subsidiaries has received any (1)
written communication that alleges that Parent or any of its Subsidiaries is
in
violation of, or has liability under, any Environmental Law, (2) written request
from any Governmental Entity for information pursuant to any Environmental
Law,
or (3) written notice regarding any requirement proposed for adoption or
implementation by any Government Entity under any Environmental Law which
requirement is applicable to the operations of Parent or any of its
Subsidiaries;
(B) there
are
no Environmental Claims pending or, to the Knowledge of Parent, threatened,
against Parent or any of its Subsidiaries;
(C) to
the
Knowledge of Parent there have been no Releases of any Hazardous Material that
could be reasonably expected to form the basis of any Environmental Claim
against Parent or any of its Subsidiaries; and
(D) (1) neither
Parent nor any of its Subsidiaries has retained or assumed either contractually
or by operation of law any liabilities or obligations that could be reasonably
expected to form the basis of any Environmental Claim against Parent or any
of
its Subsidiaries, and (2) to the Knowledge of Parent, there are no Environmental
Claims against any person whose liabilities for such Environmental Claims Parent
or any
-24-
of
its
Subsidiaries has or may have retained or assumed either contractually or by
operation of law.
(j) Taxes.
(i) Parent
and
its subsidiaries have filed or has caused to be filed all Tax Returns required
to be filed by them and all such Tax Returns are complete and accurate in all
respects, except for failures to file Tax Returns, or omissions or inaccuracies
in any Tax Returns, that would not result in a Material Adverse Effect with
respect to Parent. Each of Parent and its subsidiaries has paid or caused to
be
paid all Taxes due and owing, and the most recent financial statements contained
in the Parent SEC Documents reflect an adequate reserve (excluding any reserves
for deferred Taxes) for all Taxes payable by Parent or its subsidiaries for
all
taxable periods and portions thereof accrued through the date of such financial
statements, except for failures to pay Taxes or to reflect adequate reserves
that would not result in a Material Adverse Effect with respect to
Parent.
(ii) No
deficiencies, audit examinations, refund litigation, proposed adjustments or
matters in controversy for any Taxes have been proposed, asserted or assessed
in
writing against Parent or its Subsidiaries, except for any such deficiencies,
examinations, litigation, adjustments or matters that have been resolved with
the applicable Tax authority or that would not result in a Material Adverse
Effect with respect to Parent. There is no currently effective agreement or
other document extending, or having the effect of extending, the period of
assessment or collection of any material Taxes of Parent.
(iii) Parent
has
complied in all respects with all applicable statutes, laws, ordinances, rules
and regulations relating to the withholding of Taxes (including withholding
of
Taxes pursuant to Sections 1441, 1442, 3121 and 3402 of the Code and similar
provisions under any Federal, state, local or foreign Tax laws) and has, within
the time and the manner prescribed by law, withheld from and paid over to the
proper Governmental Entity all amounts required to be so withheld and paid
over
under applicable laws, except, in each case, for any failures that would not
result in a Material Adverse Effect with respect to Parent.
(k) Voting
Requirements.
The
affirmative vote in favor of the establishment and issuance of the Parent
Preferred Stock (including any related amendment to the Certificate of
Incorporation of Parent) at the Parent Stockholders Meeting or any adjournment
or postponement thereof of the holders of a majority of Parent Common Stock
casting votes at the Parent Stockholders Meeting (the “Parent
Stockholder Approval”)
is the
only vote of the holders of any class or series of Parent’s capital stock
necessary to approve, in accordance with the applicable rules of by the American
Stock Exchange, Inc. (the “AMEX”)
on the
Closing Date, the issuance of the Parent Preferred Stock in connection with
the
Merger. No other approval of the stockholders of Parent required with respect
to
this Agreement or the transactions contemplated hereby or by the Voting
Agreement.
-25-
(l) Brokers.
No
broker, investment banker, financial advisor or other person, other than
Avondale Partners, LLC, the fees, commissions and expenses of which will be
paid
by NHC/OP Sub, is entitled to any broker’s, finder’s, financial advisor’s or
other similar fee or commission, or the reimbursement of expenses, in connection
with the transactions contemplated by this Agreement or the Voting Agreement
based upon arrangements made by or on behalf of Parent or any of its
Subsidiaries.
(m) Opinion
of Financial Advisor.
The
Special Committee of the Board of Directors of Parent has received the opinion
of Avondale Partners, LLC dated the date of this Agreement, to the effect that,
as of such date, the Merger Consideration is fair from a financial point of
view
to NHC/OP Sub and Parent, a signed copy of which opinion has been delivered
to
the Company.
ARTICLE
IV
COVENANTS
RELATING TO CONDUCT OF BUSINESS
SECTION
4.01. Conduct
of Business.
(a) Conduct
of Business by the Company.
During
the period from the date of this Agreement to the Effective Time, except as
consented to in writing by NHC/OP Sub or in the ordinary course of business,
consistent with past practice, the Company shall not, and shall not permit
any
of its Subsidiaries to:
(i) (A) declare,
set aside or pay any dividends on, or make any other distributions (whether
in
cash, stock, property or otherwise) in respect of, any of its capital stock
or
other equity or voting interests or securities, except for (1) dividends and
distributions by a direct or indirect wholly owned Subsidiary of the Company
to
its parent, and (2) the 2006 Dividend and the REIT Dividend, (B) split, combine
or reclassify any of its capital stock or other equity or voting interests
or
securities or issue or authorize the issuance of any other securities in respect
of, in lieu of or in substitution for shares of its capital stock or any other
equity or voting interests or securities, or (C) purchase, redeem or otherwise
acquire any shares of capital stock or other equity or voting interests or
securities of the Company or any of its Subsidiaries or any securities
convertible into, or exchangeable or exercisable for, or any rights, warrants,
calls or options to acquire, any such shares or other equity or voting interests
or securities;
(ii) other
than
as set forth on Section 4.01(a)(ii) of the Company Disclosure Schedule, issue,
deliver, sell, grant, pledge, dispose of or otherwise encumber or subject to
any
Lien any shares of its capital stock, any other equity or voting interests
or
securities or any securities convertible into, or exchangeable or exercisable
for, or any rights, warrants, calls or options to acquire, (i) any such
shares or equity or voting interests or securities, or (2) any “phantom”
stock, “phantom” stock rights or any stock appreciation rights, stock based
performance units or other rights that are linked to the price of Company Common
Stock, other than the issuance of shares of Company Common Stock upon the
exercise of the
-26-
Company
Stock Options outstanding as of the date of this Agreement in accordance with
their terms as in effect on the date of this Agreement;
(iii) amend
or
propose to amend the Company charter or the bylaws of the Company or the
comparable organizational documents of any of the Company’s Subsidiaries, except
as required by law;
(iv) directly
or indirectly acquire or agree to acquire by merging or consolidating with,
or
by purchasing assets of, or by any other manner, any person or division,
business or equity interest of any person;
(v) terminate
the Management Agreement;
(vi) except
as
otherwise contemplated by this Agreement or as required to comply with
applicable law or the terms of any collective bargaining agreement, Company
Benefit Plan or Company Benefit Agreement as in effect on the date of this
Agreement, (A) adopt, enter into, terminate or amend (1) any collective
bargaining agreement, Company Benefit Plan (including any Company Stock Plan)
or
Company Benefit Agreement, (B) increase in any manner the compensation, bonus
or
fringe or other benefits of, any current or former director, officer, employee
or consultant of the Company or any of its Subsidiaries or grant any type of
compensation, bonus or fringe or other benefits, to any current or former
director, officer, employee or consultant of the Company or any of its
Subsidiaries not previously receiving or entitled to receive such type of
compensation, bonus or fringe or other benefit, except for normal increases
in
cash compensation other than to officers or directors in the ordinary course
of
business consistent with past practice, (C) pay any benefit or amount
(including by granting or accelerating the vesting of any equity-based awards)
not required under any Company Benefit Plan or Company Benefit Agreement as
in
effect on the date of this Agreement or (D) grant any severance or termination
pay or increase in any manner the severance or termination pay of any current
or
former director, officer, employee or consultant of the Company or any of its
Subsidiaries;
(vii) change
its
fiscal year, revalue any of its material assets or, except as required by a
change in GAAP or applicable law, make any changes in financial or accounting
methods, principles or practices;
(viii) take
any
action that would cause the Company not to qualify and be taxable as a REIT
under the Code;
(ix) authorize,
commit or agree to take any of the foregoing actions or any action which would
(A) make any of the representations and warranties of the Company that are
qualified as to materiality untrue or incorrect, (B) make any of the
representations and warranties of the Company which are not so qualified untrue
or incorrect in a material respect or (C) be reasonably likely to result in
any
of the conditions to the Merger set forth in this Agreement not being
satisfied;
-27-
(x) carry
on
their respective businesses other than in the usual, regular and ordinary course
in all material respects, in substantially the same manner as heretofore
conducted, or fail to use other than their respective reasonable best efforts
to
keep available the services of their respective present officers and key
employees, preserve intact their present lines of business, maintain their
rights and franchises and preserve their relationships with customers, suppliers
and others having business dealings with them to the end that their ongoing
businesses shall not be impaired in any material respect at the Effective
Time;
(xi) (A) enter
into
any new material line of business or (B) incur or commit to any capital
expenditures or any obligations or liabilities in connection therewith other
than capital expenditures and obligations or liabilities in connection therewith
incurred or committed to in the ordinary course of business;
(xii) other
than
as set forth on Section 4.01(a)(xii) of the Company Disclosure Schedule, sell,
lease or otherwise dispose of any of its assets (including the capital stock
of
Subsidiaries of the Company) other than in the ordinary course of
business;
(xiii) (A)
enter
into any joint venture, partnership or similar arrangement, (B) make any
loans, advances or capital contributions to, or investments in, any other
person, other than loans or investments by the Company or a Subsidiary of the
Company in the Company or any Subsidiary of the Company, or (C) incur any
indebtedness for borrowed money or guarantee any such indebtedness of another
person, issue or sell any debt securities or warrants or other rights to acquire
any debt securities of the Company or any of its Subsidiaries, guarantee any
debt securities of another person, enter into any “keep well” or other agreement
to maintain any financial statement condition of another person (other than
any
wholly owned Subsidiary) or enter into any arrangement having the economic
effect of any of the foregoing, other than refinancings of pre-existing
indebtedness;
(xiv) (A) modify,
amend or terminate any Material Contract of the Company or any of its
Subsidiaries, (B) waive any material rights under any Material Contract of
the
Company or any of its Subsidiaries or (C) enter into any agreement that would
constitute a Material Contract of the Company or any of its Subsidiaries if
entered into as of the date of this Agreement, other than (with respect to
clauses (A) and (C)) in the ordinary course of business consistent with past
practice;
(xv) settle
or
compromise any claim, demand, lawsuit or state or federal regulatory proceeding,
whether now pending or hereafter made or brought, or waive, release or assign
any rights or claims in any case without the prior written consent of NHC/OP
Sub; or
(xvi) commit
any
act or omission which constitutes a material breach or default by the Company
or
any of its Subsidiaries under any agreement with any Governmental Entity or
under any material contract or material license to which
-28-
any
of
them is a party or by which any of them or their respective properties is bound,
except to the extent required by law;
provided
that
nothing herein shall prohibit the Company Reorganization or the
Consolidation.
(b) Conduct
of Business by Parent.
During
the period from the date of this Agreement to the Effective Time, except as
consented to in writing by the Company, Parent shall not, and shall not permit
any of its Subsidiaries to:
(i) (A) declare,
set aside or pay any dividends on, or make any other distributions (whether
in
cash, stock, property or otherwise) in respect of, any of its capital stock
or
other equity or voting interests or securities, except for (1) dividends and
distributions (including liquidating distributions) by a direct or indirect
wholly owned Subsidiary or Parent to its parent, or (2) normal quarterly
cash dividends by Parent to the holders of Parent Common Stock, or (B) split,
combine or reclassify any of its capital stock or other equity or voting
interests or securities or issue or authorize the issuance of any other
securities in respect of, in lieu of or in substitution for shares of its
capital stock or any other equity or voting interests or
securities;
(ii) amend
or
propose to amend the certificate of incorporation or the by-laws of Parent
or
the comparable organizational documents of any of Parent’s Subsidiaries, except
in accordance with the terms of this Agreement (including in connection with
the
authorization of the Parent Preferred Stock) or as required by law;
(iii) change
its
fiscal year, revalue any of its material assets or, except as required by a
change in GAAP or applicable law, make any changes in financial, accounting
methods, principles or practices; or
(iv) authorize,
commit or agree to take any of the foregoing actions or any action which would
(A) make any of the representations and warranties of NHC/OP Sub, NHC/OP and
Parent that are qualified as to materiality untrue or incorrect, (B) make any
of
the representations and warranties of NHC/OP Sub, NHC/OP and Parent which are
not so qualified untrue or incorrect in a material respect or (C) be reasonably
likely to result in any of the conditions to the Merger set forth in this
Agreement not being satisfied or cause the Company to do any of the
foregoing.
(c) Advice
of Changes; Filings.
Subject
to applicable laws relating to the confidentiality of information, each of
the
Company and NHC/OP Sub shall promptly advise the other party orally and in
writing of (i) any representation or warranty made by it (and, in the case
of
NHC/OP Sub, made by Parent) contained in this Agreement that is qualified as
to
materiality becoming untrue or inaccurate in any respect or any such
representation or warranty that is not so qualified becoming untrue or
inaccurate in any material respect or (ii) the failure of it (and, in the case
of NHC/OP Sub, of Parent) to comply with or satisfy in any material respect
any
covenant, condition or agreement to be
-29-
complied
with or satisfied by it under this Agreement; provided, however, that no such
notification shall affect the representations, warranties, covenants or
agreements of the parties (or remedies with respect thereto) or the conditions
to the obligations of the parties under this Agreement. The Company and NHC/OP
Sub shall each promptly provide the other copies of all filings made by such
party (and, in the case of NHC/OP Sub, by Parent) with any Governmental Entity
in connection with this Agreement and the transactions contemplated hereby,
other than the portions of such filings that include confidential information
not directly related to the transactions contemplated by this
Agreement.
SECTION
4.02. No
Solicitation.
(a) The
Company and its Subsidiaries and the officers and directors of the Company
and
its Subsidiaries shall not, and the Company and its Subsidiaries shall use
their
respective best efforts to cause the Company’s and its Subsidiaries’ other
employees and any investment banker, financial advisor, attorney, consultant,
accountant or other representative of the Company or any of its Subsidiaries
(collectively, the “Representatives”)
not to,
directly or indirectly, (i) solicit, initiate or encourage, or take any other
action to facilitate any Company Takeover Proposal, (ii) provide any nonpublic
information or data to any person relating to a Company Takeover Proposal,
or
engage in any negotiations concerning a Company Takeover Proposal, or knowingly
facilitate any effort or attempt to make or implement a Company Takeover
Proposal, (iii) approve or recommend, or propose publicly to approve or
recommend, any Company Takeover Proposal, (iv) approve or recommend, or propose
to approve or recommend, or execute or enter into, any letter of intent,
agreement in principle, merger agreement, asset purchase or share exchange
agreement, option agreement or other similar agreement (other than a
confidentiality agreement to the extent permitted by this Section
4.02),
or (v)
agree to do any of the foregoing related to any Company Takeover Proposal.
The
term “Company
Takeover Proposal”
means
any inquiry, proposal or offer from any person relating to, or that is
reasonably likely to lead to (x) a proposal or offer with respect to a
merger, reorganization, share exchange, consolidation, business combination,
recapitalization, liquidation, dissolution or similar transaction involving,
or
any purchase directly or indirectly (including by way of lease, exchange, sale,
mortgage, pledge, tender offer, exchange offer or otherwise, as may be
applicable) of any assets (other than sales of investment securities in the
ordinary course of business) of the Company or any of its Subsidiaries or any
shares of Company Common Stock or other class of capital stock of, or any other
equity or voting interests in, the Company or any of its Subsidiaries, (y)
a
breach of any of the provisions of this Agreement or any interference with
the
completion of the Merger or (z) any public announcement of a proposal, plan
or
intention to do any of the foregoing or any agreement to engage in any of the
foregoing; provided
that
nothing herein shall prohibit the Company Reorganization or the
Consolidation;
(b) Notwithstanding
the foregoing, at any time prior to obtaining the Company Stockholders Approval,
the Board of Directors of the Company may (A) to the extent applicable, comply
with Rule 14d-9 and Rule 14e-2 promulgated under the Exchange Act with regard
to
a Company Takeover Proposal or make any disclosures as to factual matters that
are required by applicable law or which a majority of a committee composed
of
disinterested members of the Board of Directors of the Company (such committee,
the
-30-
“Special
Committee”),
after
consultation with outside counsel, determines in good faith is required in
the
exercise of its fiduciary duties under applicable law, (B) withdraw or modify
in
a manner adverse to NHC/OP Sub or Parent, or propose to publicly withdraw or
modify in a manner adverse to NHC/OP Sub or Parent, the approval or
recommendation of the Board of Directors of the Company of this Agreement or
the
Merger (a “Change
in Company Recommendation”)
or (C)
engage in any discussions or negotiations with, or furnish any information
with
respect to the Company and its Subsidiaries to, any person in response to an
unsolicited bona fide written Company Takeover Proposal by any such person
first
made after the date of this Agreement, if and only to the extent that, in any
such case referred to in clause (B) or (C): (i) the Company has complied in
all
material respects with this Section
4.02;
(ii) the
Special Committee, after consultation with outside counsel, determines in good
faith that such action is required in the exercise of its fiduciary duties
under
applicable law; (iii) in the case of clause (B) above, (I) if the Company has
received an unsolicited bona fide written Company Takeover Proposal from a
third
party, the Special Committee concludes in good faith that such Company Takeover
Proposal constitutes a Superior Proposal after giving effect to all of the
adjustments that may be offered by NHC/OP Sub pursuant to clause (III) below,
(II) it has notified NHC/OP Sub, at least five business days in advance of
its
intention to effect a Change in Company Recommendation, specifying the material
terms and conditions of any such Superior Proposal and furnishing to NHC/OP
Sub
a copy of the relevant proposed transaction agreements with the party making
such Superior Proposal and other material documents and (III) prior to effecting
such a Change in Company Recommendation, it has, and has caused its financial
and legal advisors to, negotiate with NHC/OP Sub in good faith to make such
adjustments in the terms and conditions of this Agreement as would enable it
to
proceed with the Merger and the other transactions contemplated hereby without
violating its fiduciary duties under applicable law (it being understood NHC/OP
Sub shall have no such obligation to change any terms or conditions of this
Agreement); (iv) in the case of clause (C) above, the Special Committee
concludes in good faith that there is a reasonable likelihood that such Company
Takeover Proposal constitutes a Superior Proposal, and prior to furnishing
any
information with respect to the Company or its Subsidiaries in connection with
the Company Takeover Proposal, the Special Committee receives from such person
an executed confidentiality agreement having provisions that are no less
favorable to the Company than those contained in the Confidentiality Agreement;
and (v) the Company immediately (and in any event prior to furnishing any
information with respect to the Company or its Subsidiaries to any person or
entering into discussions or negotiations with any person) notifies NHC/OP
Sub
of such inquiries, proposals or offers received by, any such information
requested from, or any such discussions or negotiations sought to be initiated
or continued with, it or any of its Representatives indicating, in connection
with such notice, the identity of such person and the material terms and
conditions of any inquiries, proposals or offers (including a copy thereof
if in
writing and any related documentation or correspondence) and advises NHC/OP
Sub
of any material developments (including any changes in such terms and
conditions) with respect to such inquiries, proposals or offers as promptly
as
practicable after the occurrence thereof.
(c) The
Company agrees that it will immediately cease and cause its Subsidiaries, and
its and their Representatives, to cease any and all existing activities,
discus-
-31-
sions
or
negotiations with any third parties conducted heretofore with respect to any
Company Takeover Proposal, and request in writing to any such third parties
in
possession of nonpublic information about it or any of its Subsidiaries that
was
furnished by or on its behalf in connection with any of the foregoing to return
or destroy all such information in the possession of any such third party or
in
the possession of any representative of any such third party, and use
commercially reasonable efforts to receive certification of such return or
destruction, and it will not release any third party from, or waive any
provisions of, any confidentiality or standstill agreement to which it or any
of
its Subsidiaries is a party with respect to any Company Takeover
Proposal.
(d) Any
disclosure (other than a “stop, look and listen” or similar communication of the
type contemplated by Rule 14d-9(f) under the Exchange Act) made pursuant to
clause (A) of Section
4.02(b)
shall be
deemed to be a Change in Company Recommendation unless the Board of Directors
of
the Company expressly reaffirms that the Merger is advisable, fair to and in
the
best interests of the Company’s stockholders and recommends that the Company’s
stockholders vote in favor of the adoption of this Agreement in such
disclosure.
ARTICLE
V
ADDITIONAL
AGREEMENTS
SECTION
5.01. Preparation
of the Form S-4, the Joint Proxy Statement and the Schedule
13E-3.
As soon
as practicable following the date of this Agreement, the Company and Parent
shall (a) prepare and file with the SEC the Joint Proxy Statement and the
Schedule 13E-3 and (b) Parent shall prepare and file with the SEC the Form
S-4,
in which the Joint Proxy Statement will be included as a prospectus. Each of
the
Company and Parent shall and shall cause their respective counsel, accountants
and other advisors to use all reasonable best efforts to have the Form S-4
declared effective under the Securities Act as promptly as practicable after
such filing (including causing accountants to deliver necessary or required
instruments such as opinions, consents and certifications) and to keep the
Form
S-4 effective for so long as necessary to complete the Merger. The Company
will
cause (and will make provision that its successor cause) the Joint Proxy
Statement to be mailed to the Company’s stockholders for purposes of approving
the Consolidation and the Merger, and Parent will cause the Joint Proxy
Statement to be mailed to Parent’s stockholders, in each case as promptly as
practicable after the Form S-4 is declared effective under the Securities Act.
Parent shall also take any action (other than qualifying to do business in
any
jurisdiction in which it is not now so qualified or filing a general consent
to
service of process) reasonably required to be taken under any applicable state
securities laws in connection with the issuance of Parent Preferred Stock in
the
Merger, and the Company shall furnish all information concerning the Company
and
the holders of Company Common Stock as may be reasonably requested by Parent
in
connection with any such action and the preparation, filing and distribution
of
the Joint Proxy Statement and the Form S-4. The parties shall cooperate and
notify each other promptly of the receipt of any comments from the SEC or the
staff of the SEC and of any request by the SEC or the staff of the SEC for
amendments or supplements to the Joint Proxy Statement, the Form S-4 or the
Schedule 13E-3 or for additional information, and shall supply each other with
copies of all correspondence between it or any of its Representatives, on the
one hand, and the SEC or the staff of the SEC, on the other hand, with
-32-
respect
to
the Joint Proxy Statement, the Form S-4, the Schedule 13E-3, the Merger or
the
other transactions contemplated by this Agreement or the Voting Agreement.
No
filing of, or amendment or supplement to, the Form S-4 will be made by Parent,
and no filing, or amendment or supplement to, the Joint Proxy Statement or
the
Schedule 13E-3 will be made by Parent or the Company, in each case (i) without
providing the other party a reasonable opportunity to review and comment thereon
or (ii) without the approval of both Parent and the Company, which approval
shall not be unreasonably withheld or delayed; provided, that, with respect
to
documents filed by a party hereto that are incorporated by reference in the
Form
S-4 or Joint Proxy Statement, this right of approval shall apply only with
respect to information relating to the other party or its business, financial
condition or results of operations or the Merger. If at any time prior to the
Effective Time any information relating to the Company or Parent, or any of
their respective Affiliates, directors or officers, should be discovered by
the
Company or Parent which should be set forth in an amendment or supplement to
any
of the Form S-4, the Joint Proxy Statement or the Schedule 13E-3 (including
the
consummation of the Company Reorganization or the Consolidation), so that any
such document would not include any misstatement of a material fact or omit
to
state any material fact necessary to make the statements therein, in light
of
the circumstances under which they were made, not misleading, the party that
discovers such information shall promptly notify the other parties hereto and
an
appropriate amendment or supplement describing such information shall be
promptly filed with the SEC and, to the extent required by law, disseminated
to
the stockholders of Parent and the stockholders of the Company.
SECTION
5.02. Stockholder
Meetings.
(a) Company
Stockholders Meeting for Consolidation.
The
Company shall (i) as soon as practicable following the date of this Agreement,
establish a record date (which shall be as soon as practicable following the
date of this Agreement) for, duly call, give notice of, convene and hold a
meeting of its stockholders, which meeting shall not, in any event, take place
later than 30 days after the mailing of the Joint Proxy Statement to the
Company’s stockholders for the purpose of obtaining Approval of the
Consolidation (as defined in Section
6.01(a))
and (ii)
subject to Section
4.02(b),
through
its Board of Directors, acting upon the recommendation of the Special Committee,
unless their fiduciary duties require otherwise, recommend to its stockholders
the approval of the Consolidation.
(b) Company
Stockholders Meeting for Merger.
The
Company shall (i) as soon as practicable following Approval of Consolidation,
establish a record date (which shall be as soon as practicable following the
date of Approval of Consolidation) for, duly call, give notice of, convene
and
hold a meeting of its stockholders, which meeting shall not, in any event,
take
place later than 30 days after the mailing of the Joint Proxy Statement to
the
Company’s stockholders for the purpose of obtaining Approval of the Merger (as
defined in Section
6.01(a),
such
meeting together with the meeting for purposes of Approval of Consolidation,
collectively, the “Company
Stockholders Meeting”)
and
(ii) subject to Section
4.02(b),
through
its Board of Directors, acting upon the recommendation of the Special Committee,
unless their fiduciary duties require otherwise, recommend to its stockholders
the adoption of this Agreement.
-33-
(c) Parent
Stockholders Meeting.
Parent
shall (i) establish a record date (which shall be as soon as practicable
following the date of Approval of Consolidation by the stockholders of the
Company) for, duly call, give notice of, convene and hold a meeting of its
stockholders (the “Parent
Stockholders Meeting”)
for the
purpose of obtaining the Parent Stockholder Approval and (ii) through its Board
of Directors, acting upon the recommendation of a committee comprised of a
majority of the disinterested members of its Board of Directors, unless their
fiduciary duties require otherwise, recommend to its stockholders the approval
of the issuance of Parent Preferred Stock in connection with the
Merger.
SECTION
5.03. Access
to Information; Confidentiality.
Subject
to the terms of the confidentiality agreement between Parent and the Company
dated as of March 17, 2006, as extended by amendment on October 9, 2006 (the
“Confidentiality
Agreement”),
upon
reasonable notice, each party shall, and shall cause each of its Subsidiaries
to, afford to the other party and to their officers, directors and
Representatives, reasonable and prompt access (including for the purpose of
coordinating integration activities and transition planning with the employees
of the Company and its Subsidiaries) during normal business hours during the
period prior to the earlier of the Effective Time and the termination of this
Agreement to all their respective properties, assets, books, contracts,
commitments, personnel and records and, during such period, each party shall,
and shall cause each of its Subsidiaries to, furnish promptly to the other
party
(a) a copy of each report, schedule, registration statement, form and other
document (including all exhibits and all other information incorporated therein)
filed by it during such period pursuant to the requirements of domestic or
foreign (whether national, Federal, state, provincial, local or otherwise)
securities laws and (b) all other information concerning the Company’s (and its
Subsidiaries’) business, properties, assets, books, contracts, commitments,
personnel and records as the other party may reasonably request. Except for
disclosures expressly permitted by the terms of the Confidentiality Agreement,
each party shall hold, and shall cause its directors, officers, employees,
accountants, counsel, financial advisors and other Representatives to hold,
all
information received from the other party, directly or indirectly, in confidence
in accordance with the Confidentiality Agreement.
SECTION
5.04. Reasonable
Efforts.
Upon the
terms and subject to the conditions set forth in this Agreement, each of the
parties agrees to use its reasonable best efforts to take, or cause to be taken,
all actions, and to do, or cause to be done, and to assist and cooperate with
the other parties in doing, all things necessary, proper or advisable to
consummate and make effective, in the most expeditious manner practicable,
the
Merger and the other transactions contemplated by this Agreement or the Voting
Agreement, including using commercially reasonable efforts to accomplish the
following: (i) the taking of all reasonable acts necessary to cause the
conditions to Closing set forth in Article
VI
to be
satisfied as promptly as practicable; (ii) the obtaining of all necessary
actions or nonactions, waivers, consents, approvals, orders and authorizations
from Governmental Entities and the making of all necessary registrations and
filings (including the filing of any premerger notification and report form
under the HSR Act); and (iii) the obtaining of all necessary waivers, consents,
approvals or authorizations from third parties. The Company, NHC/OP Sub, NHC/OP
and Parent shall provide such assistance, information and cooperation to each
other as is reasonably required to obtain any such actions, nonactions, waivers,
consents, approvals, orders and authorizations and, in connection therewith,
will notify the other party promptly following the receipt of any comments
from
any Governmental Entity and of any
-34-
request
by
any Governmental Entity for amendments, supplements or additional information
in
respect of any registration, declaration or filing with such Governmental Entity
and shall supply the other person with copies of all correspondence between
such
person or any of its representatives, on the one hand, and any Governmental
Entity,
on
the other hand.
SECTION
5.05. Company
Reorganization and Consolidation.
The
Company agrees to effect the Company Reorganization and the Consolidation when
the conditions set forth in Section
6.01
(other
than filing of the Articles of Consolidation) and 6.02
are
satisfied.
SECTION
5.06. [Intentionally
Omitted]
SECTION
5.07. Indemnification,
Exculpation and Insurance.
(a) NHC/OP
Sub
and Parent agree that all rights to indemnification and exculpation from
liabilities for acts or omissions occurring at or prior to the Effective Time
now existing in favor of the current or former directors or officers of the
Company and its Subsidiaries as provided in their respective certificates of
incorporation or by-laws (or comparable organizational documents) and any
indemnification or other similar agreements of the Company or any of its
Subsidiaries, in each case as in effect on the date of this Agreement and listed
on Section
5.07
of the
Company Disclosure Schedule, shall be assumed by the Surviving Person in the
Merger, without further action, as of the Effective Time and shall survive
the
Merger and shall continue in full force and effect in accordance with their
terms for six years following the Merger.
(b) In
the
event that the Surviving Person or any of its successors or assigns (i)
consolidates with or merges into any other person and is not the continuing
or
surviving corporation or entity of such consolidation or merger or (ii)
transfers or conveys all or substantially all of its properties and assets
to
any person, then, and in each such case, NHC/OP Sub shall cause proper provision
to be made so that the successors and assigns of the Surviving Person assume
the
obligations set forth in this Section
5.07.
(c) For
four
years after the Effective Time, NHC/OP Sub shall maintain in effect the
Company’s current directors’ and officers’ liability insurance in respect of
acts or omissions occurring prior to the Effective Time, covering each person
covered as of the date hereof by the Company’s directors’ and officers’
liability insurance policy (a true, complete and correct copy of which has
heretofore been delivered to NHC/OP Sub), on terms with respect to such coverage
and amounts no less favorable in any material respect than those of such policy
in effect on the date of this Agreement; provided that NHC/OP Sub may substitute
therefor a policy or policies of a reputable insurance company containing terms
with respect to coverage and amount no less favorable in any material respect
to
such insured persons.
(d) The
provisions of this Section
5.07
(i) shall
survive consummation of the Merger, (ii) are intended to be for the benefit
of,
and will be enforceable by, each indemnified or insured party, his or her heirs
and his or her representatives and (iii) are in addition to, and not in
substitution for, any other rights to indemnification or contribution that
any
such person may have by contract or otherwise.
-35-
SECTION
5.08. Fees
and Expenses.
Except
as provided in this Section
5.08
and
Section
7.02,
all fees
and expenses incurred in connection with the Merger, this Agreement, the Voting
Agreement and the other transactions contemplated hereby and thereby shall
be
paid by the party incurring such fees or expenses, whether or not the Merger
is
consummated, except that NHC/OP Sub shall bear and pay all of (i) the costs
and
expenses incurred in connection with the filing, printing and mailing of the
Form S-4 and the Joint Proxy Statement (including SEC filing fees) and (ii)
the
filing fees (A) for the premerger notification and report forms under the HSR
Act and (B) incurred in connection with any other applicable competition, merger
control, antitrust or similar law or regulation.
SECTION
5.09. Public
Announcements.
NHC/OP
Sub and Parent, on the one hand, and the Company, on the other hand, shall
consult with each other before issuing, and provide each other the opportunity
to review and comment upon, any press release or other public statements with
respect to the transactions contemplated by this Agreement, including the Merger
or the Voting Agreement, and shall not issue any such press release or make
any
such public statement prior to such consultation, except as may be required
by
applicable law or by obligations pursuant to any listing agreement with or
rules
of any national securities exchange or national securities quotation system.
The
parties agree that the initial press release to be issued with respect to the
transactions contemplated by this Agreement and the Voting Agreement shall
be in
the form previously agreed to by the parties.
SECTION
5.10. Affiliates.
As soon
as practicable after the date hereof (and, in any case, no later than the date
of the mailing of the Joint Proxy Statement with respect to the Merger), the
Company shall deliver to Parent a letter identifying all persons who are, or
are
expected to be, at the time this Agreement is submitted for adoption by the
stockholders of the Company, “affiliates” of the Company for purposes of Rule
145 under the Securities Act. The Company shall use its commercially reasonable
efforts to cause each such person to deliver to NHC/OP Sub at least 30 calendar
days prior to the Closing Date a written agreement substantially in the form
attached as Exhibit
B
hereto.
SECTION
5.11. AMEX
Listing.
Parent
shall use its reasonable best efforts to cause the shares of Parent Preferred
Stock issuable in the Merger to be approved for listing on the AMEX, subject
to
official notice of issuance, prior to the Closing Date.
SECTION
5.12. Tax
Treatment.
The
parties hereto intend to treat the Merger, for all applicable income tax
purposes, as a taxable sale by the Company of all of its assets (subject to
all
of its liabilities) to NHC/OP in exchange for the Merger Consideration, followed
by a taxable liquidation of the Company.
SECTION
5.13. Rule
16b-3.
The
Board of Directors of the Company (or the compensation committee of such Board
of Directors) and Parent shall each grant all approvals and take all other
actions required pursuant to Rules 16b-3(d) and 16b-3(e) under the Exchange
Act
to cause the disposition in the Merger of the Company Common Stock and Company
Stock Options and the acquisition in the Merger of Parent Preferred Stock and
Adjusted Options, if any, to be exempt from the provisions of Section 16(b)
of
the Exchange Act.
-36-
ARTICLE
VI
CONDITIONS
PRECEDENT
SECTION
6.01. Conditions
to Each Party’s Obligation to Effect the Merger.
The
respective obligation of each party to effect the Merger is subject to the
satisfaction or (to the extent permitted by applicable law) waiver on or prior
to the Closing Date of the following conditions:
(a) Stockholder
Approvals.
The
Consolidation shall have been approved by the Requisite Stockholder Vote and
the
Articles of Consolidation shall have been filed with, and accepted for record
by, the State Department of Assessment and Taxation of Maryland. The Merger
shall have been approved by the Requisite Stockholder Vote of the Consolidated
Company. For these purposes, “Requisite Stockholder Vote” shall mean (i) the
affirmative approval of a majority of all votes entitled to be cast on the
matter and (ii) the affirmative vote of a majority of all votes entitled to
be
cast on the matter, except those that may be cast by Affiliated Stockholders.
As
used herein, “Affiliated
Stockholder”
means
a
stockholder who is a director or officer of the Company, the Consolidated
Company, any of their Affiliates or Parent or who is otherwise an Affiliate
of
the Company.
(b) HSR
Act.
The
waiting period (and any extension thereof) applicable to the Merger under the
HSR Act or any other applicable competition, merger control, antitrust or
similar law or regulation shall have been terminated or shall have
expired.
(c) No
Injunctions or Restraints.
No
temporary restraining order, preliminary or permanent injunction or other
judgment or order or decree issued by any court of competent jurisdiction or
other statute, law, rule, legal restraint or prohibition (collectively,
“Restraints”)
shall
be in effect (i) preventing the consummation of the Merger or (ii) which
otherwise has had or could reasonably be expected to have a Material Adverse
Effect on either Parent or the Company.
(d) Form
S-4.
The Form
S-4 shall have become effective under the Securities Act and no stop order
suspending the effectiveness of the Form S-4 shall have been issued by the
SEC
and no proceedings for that purpose shall have been initiated or threatened
by
the SEC and not concluded or withdrawn.
(e) AMEX
Listing.
The
shares of Parent Preferred Stock issuable to the Company’s stockholders in the
Merger as contemplated by this Agreement shall have been approved for listing
on
the AMEX, subject to official notice of issuance.
(f) Company
Reorganization.
The
Company Reorganization shall have been consummated by all parties.
SECTION
6.02. Conditions
to Obligations of NHC/OP Sub and Parent.
The
obligations of NHC/OP Sub and Parent to effect the Merger are further subject
to
the satisfaction or (to the extent permitted by applicable law) waiver on or
prior to the Closing Date of the following conditions:
-37-
(a) Representations
and Warranties.
(i)
Except as a result of the Company Reorganization or the Consolidation, the
representations and warranties of the Company set forth in Section
3.01(a),
Section
3.01(c),
the
first four sentences of Section
3.01(d)
and
Section
3.01(n)
shall be
true and correct in all material respects as of the date of this Agreement
and
as of the Closing Date with the same effect as though made on the Closing Date
(except to the extent such representations and warranties expressly relate
to an
earlier date, in which case as of such date), and (ii) except pursuant to the
Company Reorganization or the Consolidation, the representations and warranties
of the Company (other than those listed in the preceding clause (i)) shall
be
true and correct in all material respects as of the date of this Agreement
and
as of the Closing Date with the same effect as though made on the Closing Date
(except to the extent such representations and warranties expressly relate
to an
earlier date, in which case as of such date), except to the extent that the
facts or matters as to which such representations and warranties referred to
in
this clause (ii) are not so true and correct as of such dates (without giving
effect to any qualifications and limitations as to “materiality” or “Material
Adverse Effect” set forth therein), individually or in the aggregate, have not
had and would not reasonably be expected to have a Material Adverse Effect
on
the Company. NHC/OP Sub shall have received a certificate signed on behalf
of
the Company by the chief executive officer and the chief financial officer
of
the Company to such effect.
(b) Performance
of Obligations of the Company.
The
Company shall have performed in all material respects all obligations required
to be performed by it under this Agreement at or prior to the Closing Date,
and
NHC/OP Sub shall have received a certificate signed on behalf of the Company
by
the chief executive officer and the chief financial officer of the Company
to
such effect.
(c) No
Litigation.
There
shall not be pending or threatened any suit, action or proceeding by any
Governmental Entity, or any Restraint resulting from any such action, (i)
challenging the acquisition by NHC/OP Sub or NHC/OP of any shares of Company
Common Stock, seeking to restrain or prohibit the consummation of the Merger
or
any of the other transactions contemplated by this Agreement or the Voting
Agreement, seeking to place limitations on the ownership of shares of Company
Common Stock (or membership interests of the Surviving Person) by NHC/OP Sub
or
NHC/OP or seeking to obtain from the Company, NHC/OP Sub, NHC/OP or Parent
any
damages that are material in relation to the Company and its Subsidiaries,
taken
as a whole, (ii) seeking to prohibit or materially limit the ownership or
operation by the Company, NHC/OP Sub, NHC/OP, Parent or any of their respective
Subsidiaries of any portion of any current business or of any current assets
of
the Company, NHC/OP Sub, NHC/OP, Parent or any of their respective Subsidiaries,
or to compel the Company, NHC/OP Sub, NHC/OP, Parent or any of their respective
Subsidiaries to divest or hold separate any portion of any current business
or
of any current assets of the Company, NHC/OP Sub, NHC/OP, Parent or any of
their
respective Subsidiaries, as a result of the Merger, (iii) seeking to prohibit
NHC/OP Sub, NHC/OP, Parent or any of their respective Subsidiaries from
effectively controlling in any material respect the business or operations
of
the Company or any of its Subsidiaries, (iv) seeking to impose limitations
on
the ability of NHC/OP Sub or any of its Affiliates to acquire or hold, or
exercise full rights of ownership of, any shares of Company Common Stock,
including the right to vote the Company Common Stock on all matters
-38-
properly
presented to the stockholders of the Company, or (v) otherwise having, or being
reasonably expected to have, a Material Adverse Effect on the
Company.
(d) No
Material Adverse Effect.
Since
the date of this Agreement, there shall not have been a Material Adverse Effect
relating to the Company.
SECTION
6.03. Conditions
to Obligations of the Company.
The
obligations of the Company to effect the Merger are further subject to the
satisfaction or (to the extent permitted by applicable law) waiver on or prior
to the Closing Date of the following conditions:
(a) Representations
and Warranties.
(i) The
representations and warranties of NHC/OP Sub, NHC/OP and Parent set forth in
Section
3.02(a),
Section
3.02(c)
and the
first four sentences of Section
3.02(d)
shall be
true and correct in all material respects as of the date of this Agreement
and
as of the Closing Date with the same effect as though made on the Closing Date
(except to the extent such representations and warranties expressly relate
to an
earlier date, in which case as of such date), and (ii) the representations
and
warranties of NHC/OP Sub, NHC/OP and Parent (other than those listed in the
preceding clause (i)) shall be true and correct in all material respects as
of
the date of this Agreement and as of the Closing Date with the same effect
as
though made on the Closing Date (except to the extent such representations
and
warranties expressly relate to an earlier date, in which case as of such date),
except to the extent that the facts or matters as to which such representations
and warranties are not so true and correct as of such dates (without giving
effect to any qualifications and limitations as to “materiality” or “Material
Adverse Effect” set forth therein), individually or in the aggregate, have not
had and would not reasonably be expected to have a Material Adverse Effect
on
NHC/OP Sub, NHC/OP or Parent. The Company shall have received a certificate
signed on behalf of NHC/OP Sub by an executive officer of NHC/OP Sub to such
effect.
(b) Performance
of Obligations of NHC/OP Sub, NHC/OP and Parent.
NHC/OP
Sub, NHC/OP and Parent shall have performed in all material respects all
obligations required to be performed by them under this Agreement at or prior
to
the Closing Date, and the Company shall have received a certificate signed
on
behalf of NHC/OP Sub by an executive officer of NHC/OP Sub to such
effect.
(c) No
Litigation.
There
shall not be pending or threatened any suit, action or proceeding by any
Governmental Entity, or any Restraint resulting from any such action, (i)
challenging the acquisition by NHC/OP Sub or NHC/OP of any shares of Company
Common Stock, seeking to restrain or prohibit the consummation of the Merger
or
any of the other transactions contemplated by this Agreement or the Voting
Agreement, seeking to place limitations on the ownership of shares of Company
Common Stock (or membership interests of the Surviving Person) by NHC/OP Sub
or
NHC/OP or seeking to obtain from the Company, NHC/OP Sub, NHC/OP or Parent
any
damages that are material in relation to the Company and its Subsidiaries,
taken
as a whole, (ii) seeking to prohibit or materially limit the ownership or
operation by the Company, NHC/OP Sub, NHC/OP, Parent or any of their respective
Subsidiaries of any portion of any current business or of any current assets
of
the Company, NHC/OP Sub, NHC/OP, Parent or any of their respective Subsidiaries,
or to compel the Company, NHC/OP Sub, NHC/OP, Parent or any
-39-
of
their
respective Subsidiaries to divest or hold separate any portion of any current
business or of any current assets of the Company, NHC/OP Sub, NHC/OP, Parent
or
any of their respective Subsidiaries, as a result of the Merger, (iii) seeking
to prohibit NHC/OP Sub, NHC/OP, Parent any of their respective Subsidiaries
from
effectively controlling in any material respect the business or operations
of
the Company or any of its Subsidiaries, (iv) seeking to impose limitations
on
the ability of NHC/OP Sub or any of its Affiliates to acquire or hold, or
exercise full rights of ownership of, any shares of Company Common Stock,
including the right to vote the Company Common Stock on all matters properly
presented to the stockholders of the Company, or (v) otherwise having, or being
reasonably expected to have, a Material Adverse Effect on NHC/OP Sub, NHC/OP
or
Parent.
(d) No
Material Adverse Effect.
Since
the date of this Agreement, there shall not have been a Material Adverse Effect
relating to NHC/OP Sub, NHC/OP or Parent.
SECTION
6.04. Frustration
of Closing Conditions.
None of
NHC/OP Sub, NHC/OP, Parent or the Company may rely on the failure of any
condition set forth in Section
6.01,
6.02
or
6.03,
as the
case may be, to be satisfied if such failure was caused by such party’s failure
to use its commercially reasonable efforts to consummate the Merger and the
other transactions contemplated by this Agreement and the Voting Agreement,
as
required by and subject to Section
5.04.
ARTICLE
VII
TERMINATION,
AMENDMENT AND WAIVER
SECTION
7.01. Termination.
This
Agreement may be terminated at any time prior to the Effective Time, whether
before or after receipt of the Company Stockholder Approvals and/or the Parent
Stockholder Approval:
(a) by
mutual
written consent of NHC/OP Sub and the Company;
(b) by
either
NHC/OP Sub or the Company, upon written notice to the other party: (i) if the
Merger shall not have been consummated by June 30, 2007; provided, however,
that
the right to terminate this Agreement pursuant to this Section
7.01(b)(i)
shall
not be available to any party whose action or failure to act has been a
principal cause of or resulted in the failure of the Merger to be consummated
on
or before such time and such action or failure to act constitutes a breach
of
this Agreement; (ii) if the Company Stockholder Approvals shall not have been
obtained by reason of the failure to obtain the required vote at a Company
Stockholders Meeting duly convened therefor or at any adjournment or
postponement thereof; (iii) if the Parent Stockholder Approval shall not have
been obtained by reason of the failure to obtain the required vote at a Parent
Stockholders Meeting duly convened therefor or at any adjournment or
postponement thereof; or (iv) if any Restraint having any of the effects set
forth in Section
6.01(c)
shall be
in effect and shall have become final and nonappealable;
(c) by
NHC/OP
Sub, upon written notice to the Company (i) if the Company shall have breached
or failed to perform any of its representations, warranties, covenants
-40-
or
agreements set forth in this Agreement which breach or failure to perform (A)
would give rise to the failure of a condition set forth in Section
6.02(a)
or
Section
6.02(b)
and (B)
is incapable of being cured by the Company by June 30, 2007 or (ii) if any
Restraint referred to in Section
6.02(c)
shall be
in effect and shall have become final and nonappealable;
(d) by
the
Company, upon written notice to NHC/OP Sub, (i) if NHC/OP Sub, NHC/OP or Parent
shall have breached or failed to perform any of its representations, warranties,
covenants or agreements set forth in this Agreement, which breach or failure
to
perform (A) would give rise to the failure of a condition set forth in
Section
6.03(a)
or
Section
6.03(b)
and
(B) is incapable of being cured by NHC/OP Sub, NHC/OP or Parent by June 30,
2007, or (ii) if, prior to June 30, 2007, the Special Committee of the Board
of
Directors of the Company shall have provided written notice to NHC/OP Sub that
the Company is prepared, upon termination of this Agreement, to enter into
a
binding written definitive agreement for a Superior Proposal; provided, however,
that, in the case of this clause (ii): (A) the Company shall have complied
with
Section
4.02
in all
material respects, (B) the Special Committee shall have reasonably concluded
in
good faith (prior to giving effect to any offer which may be made to the Company
by NHC/OP Sub pursuant to clause (C) below) in consultation with its financial
advisors and outside counsel, that such proposal is a Superior Proposal and
(C)
NHC/OP Sub does not make, within five business days after receipt of the
Company’s written notice referred to above in this clause (ii) an offer that the
Special Committee of the Board of Directors of the Company shall have reasonably
concluded in good faith in consultation with its financial advisors and outside
counsel is at least as favorable to the stockholders of the Company as the
Superior Proposal;
(e) by
NHC/OP
Sub, upon written notice to the Company, if (i) the Special Committee shall
have
failed to recommend that this Agreement and the transactions contemplated hereby
be approved and adopted by the Company’s stockholders or effected a Change in
Company Recommendation (or resolved to take any such action), whether or not
permitted by the terms hereof, or (ii) the Company failed to call or hold the
Company Stockholders Meeting in accordance with Section
5.02(a)
or to
prepare and mail to its stockholders the Proxy Statement in accordance with
Section
5.01,
or (iii)
the Company otherwise failed to comply with or perform its obligations under
Section
4.02;
or
(f) except
as
a result of the actions of any party which are a breach of this Agreement,
by
either NHC/OP Sub or the Company if the Consolidation shall not have been
approved by the Requisite Stockholder Vote.
SECTION
7.02. Effect
of Termination.
(a) Liabilities.
In the
event of termination of this Agreement by either the Company or NHC/OP Sub
as
provided in Section
7.01,
this
Agreement shall forthwith become void and have no effect, without any liability
or obligation on the part of NHC/OP Sub, NHC/OP, Parent or the Company, other
than the provisions of Section
3.01(o),
Section
3.02(l),
the
first sentence of Section
5.03,
Section
5.08,
this
Section
7.02
and
Article
VIII,
which
provisions survive such termination, and except to the extent that
-41-
such
termination results from the willful and material breach by such party of any
of
its representations, warranties, covenants or agreements set forth in this
Agreement.
(b) Payments:
(i) If
this
Agreement is terminated pursuant to Section
7.01(d)(ii)
the
Company shall pay to NHC/OP Sub the Termination Fee on the business day
following such termination.
(ii) If
(x)
this Agreement is terminated pursuant to Section
7.01(e),
in
circumstances involving the entry or proposed entry into a definitive agreement
by the Company in response to a Section 7.02 Company Takeover Proposal, and
(y)
at any time after the date of this Agreement and before such termination, a
Section 7.02 Company Takeover Proposal has been publicly disclosed or otherwise
communicated to the Special Committee, the Company shall pay to NHC/OP Sub
the
Termination Fee on the business day following such termination; provided however,
that no
such payment shall be required if, within five business days after such
announcement or other communication, the Special Committee (A) determines that
such Section 7.02 Company Takeover Proposal does not constitute a Superior
Proposal, (B) so notifies, in writing, NHC/OP Sub and the person or persons
that
made the Section 7.02 Company Takeover Proposal and (C) in the case of any
Section 7.02 Company Takeover Proposal that has been publicly disclosed, files
with the SEC, and mails to the Company’s stockholders, a supplement to the Joint
Proxy Statement describing such determination and reaffirming that the Merger
is
advisable, fair to and in the best interests of the Company’s stockholders and
recommends that the Company’s stockholders vote in favor of the adoption of this
Agreement; provided,
further,
however,
if, at
any time prior to the first anniversary of such termination, the Company or
any
of its Subsidiaries enters into a definitive agreement in respect of, or
approves or recommends, a Section 7.02 Company Takeover Proposal, or agrees
or
resolves to do any of the foregoing, the Company shall pay to NHC/OP Sub the
Termination Fee not later than the date of consummation of the transaction
relating to such Section 7.02 Company Takeover Proposal. If this Agreement
is
terminated pursuant to Section 7.01(e) in circumstances not involving the entry
or proposed entry into a definitive agreement by the Company in response to
a
Section
7.02
Company
Takeover Proposal the Company shall pay the Acquirer Expenses to NHC/OP Sub
within two business days after demand is made by NHC/OP Sub ;
(iii) If
this
Agreement is terminated pursuant to Section
7.01(c)(i),
the
Company shall pay to NHC/OP Sub the Acquirer Expenses within two business days
after demand is made by NHC/OP Sub . If at any time after the date of this
Agreement and before termination pursuant to Section
7.01(c)(i),
a
Section 7.02 Company Takeover Proposal has been publicly disclosed or otherwise
communicated to the Special Committee, the Company shall pay to NHC/OP Sub
the
Termination Fee on the business day following such termination; provided,
however,
that no
such payment shall be required if, within five Business Days after such
announcement or other communication, the Special Committee (A) determines
-42-
that
such
Section 7.02 Company Takeover Proposal does not constitute a Superior Proposal,
(B) so notifies, in writing, NHC/OP Sub and the person or persons that made
the
Section 7.02 Company Takeover Proposal and (C) in the case of any Section
7.02 Company Takeover Proposal that has been publicly disclosed, files with
the
SEC, and mails to the Company’s stockholders, a supplement to the Joint Proxy
Statement describing such determination and reaffirming that the Merger is
advisable, fair to and in the best interests of the Company’s stockholders and
recommends that the Company’s stockholders vote in favor of the adoption of this
Agreement;
(iv) If
(x)
this Agreement is terminated pursuant to Section
7.01(b)(i)
or
Section
7.01(b)(ii)
and (y)
at any time after the date of this Agreement and before such termination, a
Section 7.02 Company Takeover Proposal has been publicly disclosed or otherwise
communicated to the senior management or the Board of Directors of the Company,
the Company shall pay to NHC/OP Sub the Termination Fee on the business day
following such termination; provided,
however,
that no
such payment shall be required if, within 5 business days after such
announcement or other communication, the Special Committee (A) determines that
such Section 7.02 Company Takeover Proposal does not constitute a Superior
Proposal, (B) so notifies, in writing, NHC/OP Sub and the person or persons
that
made the Section 7.02 Company Takeover Proposal and (C) in the case of any
Section 7.02 Company Takeover Proposal that has been publicly disclosed, files
with the SEC, and mails to the Company’s stockholders, a supplement to the Joint
Proxy Statement describing such determination and reaffirming that the Merger
is
advisable, fair to and in the best interests of the Company’s stockholders and
recommends that the Company’s stockholders vote in favor of the adoption of this
Agreement; provided,
further,
however,
if, at
any time prior to the first anniversary of such termination, the Company or
any
of its Subsidiaries enters into a definitive agreement in respect of, or
approves or recommends, a Section 7.02 Company Takeover Proposal, or agrees
or
resolves to do any of the foregoing, the Company shall pay to NHC/OP Sub the
Termination Fee not later than the date of consummation of the transaction
relating to such Section 7.02 Company Takeover Proposal;
(v) If
this
Agreement is terminated pursuant to Section
7.01(d)(i),
NHC/OP
Sub shall pay the Company Expenses to the Company within two business days
after
demand is made by the Company.
(vi) All
payments under this Section
7.02
shall be
made by wire transfer of immediately available funds to the account specified
by
NHC/OP Sub or the Company, as the case may be. In no event shall the Termination
Fee be paid more than once.
(c) Each
of
the Company and NHC/OP Sub acknowledges that the agreements contained in this
Section
7.02
are
critical provisions of the transactions contemplated hereby and that without
these agreements the other party would not enter into this Agreement.
Accordingly, if any party fails to pay all amounts due to the other party on
-43-
the
dates
specified, the failing party shall pay all costs and expenses (including legal
fees and expenses) incurred by the other party in connection with any action
or
proceeding (including the filing of any lawsuit) taken by it to collect such
unpaid amounts, together with interest on such unpaid amounts at the prime
lending rate prevailing at such time, as published in The Wall Street Journal,
from the date such amounts were required to be paid until the date actually
received by the other party.
SECTION
7.03. Amendment.
This
Agreement may be amended by the parties hereto, by action taken or authorized
by
the Special Committee on behalf of the Company, by its sole managing member
on
behalf of NHC/OP Sub, by its general partner on behalf of NHC/OP and by the
Special Committee of the Board of Directors on behalf of Parent, at any time
before or after the Company Stockholder Approvals or the Parent Stockholder
Approval; provided, however, that after any such approval has been obtained,
there shall not be made any amendment that by law requires further approval
by
the stockholders of the Company or the stockholders of Parent without such
further approval having been obtained. This Agreement may not be amended except
by an instrument in writing signed on behalf of each of the parties
hereto.
SECTION
7.04. Extension;
Waiver.
At any
time prior to the Effective Time, a party may, by action taken or authorized
by
the Special Committee on behalf of the Company, by its sole managing member
on
behalf of NHC/OP Sub, by its general partner on behalf of NHC/OP and by the
Special Committee of the Board of Directors on behalf of Parent (a) extend
the time for the performance of any of the obligations or other acts of the
other parties, (b) to the extent permitted by applicable law, waive any
inaccuracies in the representations and warranties of the other parties
contained in this Agreement or in any document delivered pursuant to this
Agreement or (c) subject to the proviso of Section
7.03
and to
the extent permitted by law, waive compliance by the other party with any of
the
agreements or conditions contained in this Agreement. Any agreement on the
part
of a party to any such extension or waiver shall be valid only if set forth
in
an instrument in writing signed on behalf of such party. The failure of any
party to this Agreement to assert any of its rights under this Agreement or
otherwise shall not constitute a waiver of such rights.
ARTICLE
VIII
GENERAL
PROVISIONS
SECTION
8.01. Nonsurvival
of Representations and Warranties.
None of
the representations, warranties, covenants or agreements in this Agreement
or in
any document delivered pursuant to this Agreement shall survive the Effective
Time, except for those representations, warranties, covenants or agreements
that
by their terms apply or are to be performed, in whole or in part, after the
Effective Time.
SECTION
8.02. Notices.
All
notices, requests, claims, demands and other communications under this Agreement
shall be in writing and shall be deemed given if delivered personally,
telecopied (which is confirmed) or sent by overnight courier (providing proof
of
delivery) to the parties at the following addresses (or at such other address
for a party as shall be specified by like notice):
-44-
(a)
if to NHC/OP Sub, NHC/OP
|
National
HealthCare Corporation
|
|
or Parent, to: |
000
Xxxx Xxxxxx
|
|
Xxxxx
0000
|
||
Xxxxxxxxxxxx,
XX 00000
|
||
Facsimile
No.: (000) 000-0000
|
||
Attention:
General Counsel
|
||
with
a copy to:
|
Xxxxxx
Xxxxxx & Xxxxxxx LLP
|
|
00
Xxxx Xxxxxx
|
||
Xxx
Xxxx, XX 00000
|
||
Facsimile
No.: (000) 000-0000
|
||
Attention:
Xxxxx X. Xxxxx
|
||
Xxxxxxx
X. Xxx
|
||
(b)
if to the Company, to:
|
National
Health Realty, Inc.
|
|
000
Xxxx Xxxxxx
|
||
Xxxxx
0000
|
||
Xxxxxxxxxxxx,
XX 00000
|
||
Facsimile
No.: (000) 000-0000
|
||
Attention:
General Counsel
|
||
with
a copy to:
|
Xxxxxx
Xxxxxxx Xxxxxx & Xxxxx, LLP
|
|
000
Xxxxx Xxxxxx
|
||
Xxxxx
0000
|
||
Xxxxxxxxx,
XX 00000
|
||
Facsimile
No.: (000) 000-0000
|
||
Attention:
X. Xxxxx Xxxx
|
SECTION
8.03. Definitions.
For
purposes of this Agreement:
(a) “Acquirer
Expenses”
means
all reasonable out-of-pocket costs and expenses, including all fees and expenses
of investment bankers, attorneys, accountants and other advisors, incurred
by or
on behalf of NHC/OP Sub, NHC/OP, Parent or any of their respective Subsidiaries
in connection with or related to this Agreement and the transactions
contemplated thereby, but in no case shall the Acquirer Expenses for which
the
Company is responsible under Section
7.02
exceed
$2.0 million;
(b) an
“Affiliate”
of
any
person means another person that directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common control with,
such first person;
(c) “Business
Day”
means
any day other than Saturday, Sunday or any other day on which banks are legally
permitted to be closed in Delaware;
(d) “Code”
means
the Internal Revenue Code of 1986, as amended, and the rules and regulations
promulgated thereunder;
-45-
(e) “Company
Benefit Agreement”
means
any (i) employment, deferred compensation, consulting, severance, change of
control, termination or indemnification agreement with any director, officer,
employee or consultant of the Company or any of its Subsidiaries or (ii) any
agreement with any director, officer, employee or consultant of the Company
or
any of its Subsidiaries the benefits of which are contingent, or the terms
of
which are materially altered, upon the occurrence of a transaction involving
the
Company of a nature contemplated by this Agreement;
(f) “Company
Benefit Plan”
means
any employment, bonus, pension, profit sharing, deferred compensation, incentive
compensation, stock ownership, stock purchase, stock appreciation, restricted
stock, stock option, phantom stock, performance, retirement, thrift, savings,
stock bonus, paid time off, perquisite, fringe benefit, vacation, severance,
disability, death benefit, hospitalization, medical, welfare benefit or other
plan, program, policy or arrangement maintained, contributed to or required
to
be maintained or contributed to by the Company or any of its Subsidiaries,
in
each case providing benefits to any director, officer, employee or consultant
of
the Company or any of its Subsidiaries;
(g) “Company
Expenses”
means
all reasonable out-of-pocket costs and expenses, including all fees and expenses
of investment bankers, attorneys, accountants and other advisors, incurred
by or
on behalf of the Company or any of its Subsidiaries in connection with or
related to this Agreement and the transactions contemplated thereby, but in
no
case shall the Company Expenses exceed $2.0 million;
(h) “Knowledge”
of
any
person (that is not an individual) means, with respect to any specific matter,
the knowledge of such person’s directors, executive officers and other officers
having primary responsibility for such matter;
(i) “Material
Adverse Effect”
means,
when used in connection with the Company, NHC/OP Sub, NHC/OP or Parent, any
state of facts, change, effect, event, occurrence or condition that (i) is
materially adverse to the condition (financial or otherwise), properties,
assets, liabilities, businesses or results of operations of such party and
its
Subsidiaries, taken as a whole, or (ii) materially impedes, interferes with,
hinders or delays the consummation by such party of the Merger or the other
transactions contemplated by this Agreement or by the Voting Agreement, except
to the extent any such state of facts, change, effect, event, occurrence,
condition or development results from (A) conditions affecting the Company’s,
NHC/OP Sub’s, NHC/OP’s or Parent’s industry generally, (B) the announcement or
pendency of this Agreement, the Voting Agreement or the transactions
contemplated hereby or thereby, (C) actions taken by a party in connection
with
fulfilling its obligations hereunder, (D) changes in the trading price or volume
of Company Common Stock or Parent Common Stock, (E) changes in GAAP or (f)
the
Consolidation or the Company Reorganization;
(j) “person”
means
an
individual, corporation, partnership, limited liability company, joint venture,
association, trust, unincorporated organization or other entity;
-46-
(k) “REIT
Dividend”
means
a
dividend in an amount equal to the quarterly dividend the Company would in
the
ordinary course of business declare and pay in order to qualify as a REIT for
its taxable year commencing on January 1, 2007 and ended on the Closing
Date;
(l) “Section
7.02 Company Takeover Proposal”
means
any Company Takeover Proposal with respect to assets (including equity interests
in Subsidiaries) representing in the aggregate one-third or more of the
consolidated assets of the Company and its Subsidiaries or equity interests
representing one-third or more (in economic or voting power) of the outstanding
equity interests in the Company;
(m) a
“Subsidiary”
of
any
person means another person, an amount of the voting securities, other voting
rights or interests of which is sufficient to elect at least a majority of
its
Board of Directors or other governing body (or, if there are no such voting
securities, rights or interests, 50% or more of the equity interests of which)
is owned directly or indirectly by such first person;
(n) “Superior
Proposal”
means
a
bona fide, written proposal made by a third party to acquire, directly or
indirectly, including pursuant to a tender offer, exchange offer, merger,
consolidation, business combination, recapitalization, liquidation, dissolution
or similar transaction, for consideration consisting of cash and/or securities,
all or substantially all of the shares of Company Common Stock then outstanding
or all or substantially all the assets of the Company, which the Special
Committee shall have reasonably concluded in good faith (with the advice of
its
financial advisors and outside counsel and taking into account all legal,
financial, regulatory and other relevant aspects of the proposal and the person
making the proposal, including any break-up fees, expense reimbursement
provisions and conditions to consummation) (A) is on terms which are more
favorable to the stockholders of the Company, from a financial point of view,
than the Merger and the other transactions contemplated by this Agreement,
(B)
is not subject to any financing contingencies and is from a person that a
qualified investment bank advises the Special Committee, is financially capable
of consummating such proposal, (C) is reasonably likely of being consummated
and
(D) is not subject to due diligence; and
(o) “Termination
Fee”
means
$9,444,000.
(p) “2006
Dividend”
shall
mean that certain dividend, the record date for which shall be December 29,
2006, in the amount of $0.4325 per share of Company Common Stock or otherwise
equal to the dividend the Company determines is necessary for the Company to
declare and pay in order to qualify as a REIT for its taxable year ended
December 31, 2006.
SECTION
8.04. Interpretation.
When a
reference is made in this Agreement to an Article, a Section or an Exhibit,
such
reference shall be to an Article, a Section or an Exhibit to this Agreement
unless otherwise indicated. The table of contents and headings contained in
this
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement. Whenever the words “include”,
“includes” or “including” are used in this Agreement, they shall be deemed to be
followed by the words “without limitation”. The
-47-
words
“hereof”, “herein” and “hereunder” and words of similar import when used in this
Agreement shall refer to this Agreement as a whole and not to any particular
provision of this Agreement. The words “date hereof” shall refer to the date of
this Agreement. The term “or” is not exclusive. The word “extent” in the phrase
“to the extent” shall mean the degree to which a subject or other thing extends,
and shall not simply mean “if”. All terms defined in this Agreement shall have
the defined meanings when used in any document made or delivered pursuant hereto
unless otherwise defined therein. The definitions contained in this Agreement
are applicable to the singular as well as the plural forms of such terms and
to
the masculine as well as to the feminine and neuter genders of such term. Any
agreement, instrument or statute defined or referred to herein or in any
agreement or instrument that is referred to herein means such agreement,
instrument or statute as from time to time amended, modified or supplemented,
including (in the case of agreements or instruments) by waiver or consent and
(in the case of statutes) by succession of comparable successor statutes and
references to all attachments thereto and instruments incorporated therein.
References to a person are also to its permitted successors and assigns. Terms
used herein that are defined under GAAP are used herein as so
defined.
SECTION
8.05. Counterparts.
This
Agreement may be executed in one or more counterparts (including by facsimile),
all of which shall be considered one and the same agreement and shall become
effective when one or more counterparts have been signed by each of the parties
and delivered to the other parties.
SECTION
8.06. Entire
Agreement; No Third-Party Beneficiaries.
This
Agreement (including the documents and instruments referred to herein), the
Voting Agreement and the Confidentiality Agreement (a) constitute the entire
agreement, and supersede all prior agreements and understandings, both written
and oral, among the parties with respect to the subject matter of this
Agreement, the Voting Agreement and the Confidentiality Agreement and (b) except
for the provisions of Section
5.07,
are not
intended to confer upon any person other than the parties any rights or
remedies.
SECTION
8.07. Assignment.
Except
pursuant to the Consolidation, neither this Agreement nor any of the rights,
interests or obligations under this Agreement shall be assigned, in whole or
in
part, by operation of law or otherwise by any of the parties hereto without
the
prior written consent of the other parties and any assignment in violation
of
the preceding sentence shall be void, except that NHC/OP Sub may assign, in
its
sole discretion, any of or all its rights, interests and obligations under
this
Agreement to Parent or to any direct or indirect wholly owned Subsidiary of
Parent, but no such assignment shall relieve NHC/OP Sub of any of its
obligations hereunder. Subject to the preceding two sentences, this Agreement
will be binding upon, inure to the benefit of, and be enforceable by, the
parties and their respective successors and assigns.
SECTION
8.08. Governing
Law.
This
Agreement shall be governed by, and construed in accordance with, the laws
of
the State of Delaware, regardless of the laws that might otherwise govern under
applicable principles of conflict of laws thereof.
SECTION
8.09. Specific
Enforcement.
The
parties agree that irreparable damage would occur, and that the parties would
not have any adequate remedy at law, in the event that any of the provisions
of
this Agreement were not performed in accordance with their specific
-48-
terms
or
were otherwise breached. It is accordingly agreed that the parties shall be
entitled to an injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this Agreement in any
Federal court located in the State of Delaware or in Delaware state court,
this
being in addition to any other remedy to which they are entitled at law or
in
equity.
SECTION
8.10. Consent
to Jurisdiction.
Each of
the parties hereto (a) consents to submit itself to the personal jurisdiction
of
any Federal court located in the State of Delaware or any state court in the
State of Delaware in the event any dispute arises out of this Agreement or
any
of the transactions contemplated by this Agreement or the Voting Agreement,
(b)
agrees that it will not attempt to deny or defeat such personal jurisdiction
by
motion or other request for leave from any such court and (c) agrees that it
will not bring any action relating to this Agreement or any of the transactions
contemplated by this Agreement or the Voting Agreement in any court other than
a
Federal court sitting in the State of Delaware or a Delaware state court. Each
of the parties hereto irrevocably and unconditionally waives (and agrees not
to
plead or claim) any objection to the laying of venue of any action, suit or
proceeding arising out of this Agreement or the transactions contemplated hereby
or by the Voting Agreement in (a) any Delaware State court or (b) any Federal
court of the United States sitting in the State of Delaware, or that any such
action, suit or proceeding brought in any such court has been brought in an
inconvenient forum. Each of the parties hereto further agrees that, to the
fullest extent permitted by applicable law, service of any process, summons,
notice or document by U.S. registered mail to such person’s respective address
set forth in Section
8.02
above
shall be effective service of process for any action, suit or proceeding in
Delaware with respect to any matters to which it has submitted to jurisdiction
as set forth above in the immediately preceding sentence.
SECTION
8.11. Waiver
of Jury Trial.
Each
party hereto hereby waives, to the fullest extent permitted by applicable law,
any right it may have to a trial by jury in respect of any suit, action or
other
proceeding directly or indirectly arising out of, under or in connection with
this Agreement or the Voting Agreement. Each party hereto (a) certifies that
no
representative, agent or attorney of any other party has represented, expressly
or otherwise, that such party would not, in the event of any action, suit or
proceeding, seek to enforce the foregoing waiver and (b) acknowledges that
it
and the other parties hereto have been induced to enter into this Agreement,
by,
among other things, the mutual waiver and certifications in this Section
8.11.
SECTION
8.12. Severability.
If any
term or other provision of this Agreement is invalid, illegal or incapable
of
being enforced by any rule of law or public policy, all other conditions and
provisions of this Agreement shall nevertheless remain in full force and effect.
Upon such determination that any term or other provision is invalid, illegal
or
incapable of being enforced, the parties hereto shall negotiate in good faith
to
modify this Agreement so as to effect the original intent of the parties as
closely as possible to the fullest extent permitted by applicable law in an
acceptable manner to the end that the transactions contemplated hereby are
fulfilled to the extent possible.
SECTION
8.13. Management
Agreement.
Notwithstanding anything in this Agreement, the Company shall not be liable
for
any payment or be deemed to have breached this Agreement as a result of (i)
any
act or omission that is within the powers granted to NHC/OP Sub or its
Affiliates under the Management Agreement, or (ii) the failure of a
representation or
-49-
warranty
of the Company to be true and correct to the extent that such failure (x) is
the
result of action or inaction by NHC/OP Sub or its Affiliates in their role
as
Manager of the Company pursuant to the Management Agreement or (y) is known
or
should be known by NHC/OP Sub or its Affiliates in their role as Manager of
the
Company pursuant to the Management Agreement.
[Remainder
of Page Left Intentionally Blank]
-50-
IN
WITNESS
WHEREOF, NHC/OP Sub, NHC/OP, Parent and the Company have caused this Agreement
to be signed by their respective officers thereunto duly authorized, all as
of
the date first written above.
XXXXX
ACQUISITION SUB LLC
By:
/s/
R.
Xxxxxxx Xxxxxx
Name: R. Xxxxxxx Xxxxxx
Authorized Signatory
NHC/OP,
L.P.
By:
NHC-Delaware,
Inc.
Its
General Partner
By:
/s/
R.
Xxxxxxx Xxxxxx
Name: R. Xxxxxxx Xxxxxx
Title: Vice President
NATIONAL
HEALTHCARE CORPORATION
By:
/s/
R.
Xxxxxxx Xxxxxx
Name: R. Xxxxxxx Xxxxxx
Title: Senior V.P., Operations
NATIONAL
HEALTH REALTY, INC.
By:
/s/
Xxxxxx X. Xxxxx
Name: Xxxxxx X. Xxxxx
Title: President
S-1
ANNEX
I
TO
THE
MERGER AGREEMENT
Index
of Defined Terms
|
-1-
Term | Section |
ERISA
|
Section
3.01(r)
|
Exchange
Act
|
Section
3.01(e)(i)
|
Exchange
Agent
|
Section
2.02(a)
|
Exchange
Ratio
|
Section
2.01(b)
|
Form
S-4
|
Section
3.01(d)
|
GAAP
|
Section
3.01(e)(i)
|
Governmental
Entity
|
Section
2.02(f)
|
Hazardous
Materials
|
Section
3.01(i)(iii)(C)
|
HSR
Act
|
Section
3.01(d)
|
Holder
|
Section
2.02(k)
|
Joint
Proxy Statement
|
Section
3.01(d)
|
Knowledge
|
Section
8.03(h)
|
Legal
Provisions
|
Section
3.01(i)
|
Liens
|
Section
3.01(b)
|
Manager
|
Recitals
|
Management
Agreement
|
Recitals
|
Material
Adverse Effect
|
Section
8.03(i)
|
Material
Contract
|
Section
3.01(j)
|
MGCL
|
Section
1.01
|
Merger
|
Recitals
|
Merger
Consideration
|
Section
2.01(b)
|
NHC/OP
|
Preamble
|
NHC/OP
Sub
|
Preamble
|
NHC/OP
Sub Disclosure Schedule
|
Section
3.02
|
NHR-Delaware
Merger
|
Recitals
|
Non-Affiliated
Stockholders
|
Section
6.01(a)
|
Option
Value
|
Section
2.02(k)
|
Parachute
Gross Up Payment
|
Section
3.01(k)
|
Parent
|
Preamble
|
Parent
Common Stock
|
Section
3.02(c)
|
Parent
Preferred Stock
|
Recitals
|
Parent
SEC Documents
|
Section
3.02(e)
|
Parent
Stockholder Approval
|
Section
3.02(k)
|
Parent
Stockholders Meeting
|
Section
5.02(b)
|
Parent
Stock Options
|
Section
3.02(c)
|
Parent
Stock Plans
|
Section
3.02(c)
|
Permits
|
Section
3.01(i)
|
Permitted
Exceptions
|
Section
3.01(q)(i)(A)
|
person
|
Section
8.03(j)
|
Previously
Authorized Parent Preferred Stock
|
Section
3.02(c)
|
Record
Date
|
Section
2.03
|
REIT
Dividend
|
Section
2.03
|
Release
|
Section
3.01(i)(iii)(D)
|
Representatives
|
Section
4.02(a)
|
Restraints
|
Section
6.01(c)
|
-2-
Term | Section |
Schedule
13E-3
|
Section
3.01(d)
|
SEC
|
Section
3.01(d)
|
Section
7.02 Company Takeover Proposal
|
Section
8.03(k)
|
Securities
Act
|
Section
3.01(e)(i)
|
Special
Committee
|
Section
4.02(b)
|
Special
Dividend
|
Section
2.03
|
Subsidiary
|
Section
8.03(l)
|
Superior
Proposal
|
Section
8.03(m)
|
Surviving
Person
|
Section
1.01
|
Taxes
|
Section
3.01(l)(vi)
|
Tax
Returns
|
Section
3.01(l)(vi)
|
Termination
Fee
|
Section
8.03(n)
|
Voting
Agreement
|
Recitals
|
-3-
EXHIBIT
A
OF
SERIES
A CONVERTIBLE PREFERRED STOCK SETTING FORTH THE POWERS, PREFERENCES AND RIGHTS,
AND THE QUALIFICATIONS, LIMITATIONS AND RESTRICTIONS THEREOF, OF SUCH PREFERRED
STOCK OF NATIONAL HEALTHCARE CORPORATION
Pursuant
to Section 151 of the General Corporation Law of the State of Delaware, National
HealthCare Corporation, a Delaware corporation (the “Company”),
does
hereby certify that the Board of Directors of the Company (the “Board
of Directors”)
duly
adopted the following resolution and that such resolution has not been modified
and is in full force and effect:
RESOLVED
that, pursuant to the authority vested in the Board of Directors in accordance
with the provisions of the Certificate of Incorporation of the Company (the
“Certificate
of Incorporation”),
a
series of preferred stock of the Company is hereby created and the designation
and number of shares thereof and the voting powers, preferences and relative,
participating, optional and other special rights of the shares of such series,
and the qualifications, limitations and restrictions thereof, are as set
forth
below in this Certificate of Designations (this “Certificate”):
SECTION
1. Number;
Designation; Registered Form.
(a) The
shares
of such series shall be designated as “Series A Convertible Preferred
Stock” (the “Preferred
Stock”)
and
shall have a par value of $0.01 per share. The number of shares constituting
the
Preferred Stock shall be
[ ]. Certificates for
shares of Preferred Stock shall be issuable only in registered form.
The
Preferred Stock is being issued as part of the consideration in the merger
(the
“Merger”)
of
National Health Realty, Inc. with and into an indirect wholly owned subsidiary
of the Company.
(b) All
shares
of Preferred Stock redeemed, purchased, exchanged, converted or otherwise
acquired by the Company shall be retired and canceled and, upon the taking
of
any action required by applicable law, shall be restored to the status of
authorized but unissued shares of preferred stock of the Company, without
designation as to series, and may thereafter be reissued.
(c) Capitalized
terms used herein and not otherwise defined shall have the respective meanings
set forth in Section 10 below.
SECTION
2. Ranking.
The
Preferred Stock will rank, with respect to dividend rights and rights upon
liquidation, winding-up or dissolution:
(a) junior
to
Senior Stock;
(b) on
a
parity with Parity Stock; and
(c) senior
to
Junior Stock.
SECTION
3. Dividends.
(a) The
holders of shares of Preferred Stock will be entitled to receive, when, as
and
if dividends are declared by the Board of Directors, or any duly authorized
committee thereof, dividends at the rate of US$0.80 per annum per share of
Preferred Stock, to be payable in cash out of funds legally available therefor
on each Dividend Payment Date, as set forth below. Declared dividends will
be
payable on [ ],
[ ],
[ ] and
[ ] of each year (each, a
“Dividend
Payment Date”),
beginning on the
first
such date to occur after the Issue Date.
If any
of those dates is not a Business Day, then such dividends will be payable
on the
next succeeding Business Day. The dividends payable on any Dividend Payment
Date
will accrue from the last Dividend Payment Date or, prior to the
first
Dividend Payment Date, the Issue Date. Declared dividends will be payable
to
holders of record as they appear in the Company’s stock records at the close of
business on the date which is 30 days prior to the Dividend Payment Date;
provided,
that if
any such date is not a Business Day, then to the holders of record on the
next
succeeding Business Day (each, a “Dividend
Payment Record Date”).
Dividends payable on the shares of Preferred Stock will be computed on the
basis
of a 360-day year consisting of twelve 30-day months.
(b) Dividends
on the Convertible Preferred Stock are cumulative. If the Board of Directors
or
any authorized committee thereof fails to declare a dividend to be payable
on a
Dividend Payment Date, the dividend will accumulate on that Dividend Payment
Date until declared and paid or will be forfeited upon conversion, except
under
the circumstances described in Section 7(c) and 7(f).
(c) The
Company shall not be obligated to pay holders of Preferred Stock any interest
or
sum of money in lieu of interest on any dividend not paid on a Dividend Payment
Date or any other late payment. If the Board of Directors or an authorized
committee thereof does not declare a dividend for any Dividend Payment Date,
the
Board of Directors or an authorized committee thereof may declare and pay
the
dividend on any subsequent date, whether or not a Dividend Payment Date.
The
persons entitled to receive the dividend in such case will be holders of
Preferred Stock as they appear on the stock register on a date selected by
the
Board of Directors or an authorized committee thereof. That date must not
(a)
precede the date the Board of Directors or an authorized committee thereof
declares the dividend payable or (b) be more than 60 days prior to that
Dividend Payment Date.
SECTION
4. Liquidation
Preference.
(a) Upon
any
voluntary or involuntary liquidation, dissolution or winding-up of the Company,
each holder of Preferred Stock shall be entitled to payment out of the assets
of
the Company legally available for distribution of an amount equal to the
Liquidation Preference of the shares held by such holder, plus an amount
equal
to all accrued and unpaid and accumulated dividends on those shares to but
excluding the date of liquidation, dissolution or winding-up, before any
distribution is made on any Junior Stock, including Common Stock. After payment
in full of the Liquidation Preference and an amount equal to all accrued
and
unpaid and accumulated dividends to which holders of shares of Preferred
Stock
are entitled, such holders shall not be entitled to any further participation
in
any distribution of the assets of the Company. If, upon any voluntary or
involuntary liquidation, dissolution or winding-up of the Company, the amounts
payable with respect to shares of Preferred Stock and all other Parity Stock
are
not paid in full, the holders of shares of Preferred Stock and the holders
of
the Parity Stock shall share equally and ratably in any distribution of assets
of the Company in proportion to the full liquidation preference and an amount
equal to all accrued and unpaid and accumulated dividends, if any, to which
each
such holder is entitled.
(b) Neither
the voluntary sale, conveyance, exchange or transfer, for cash, shares of
stock,
securities or other consideration, of all or substantially all of the property
or assets of the Company nor the consolidation, merger or amalgamation of
the
Company with or into any other entity or the consolidation, merger or
amalgamation of any other entity with or into the Company shall be deemed
to be
a voluntary or involuntary liquidation, dissolution or winding-up of the
Company.
SECTION
5. Optional
Redemption.
(a) The
Company may not redeem any shares of Preferred Stock at any time before the
fifth anniversary of the Issue Date. Subject to Section 5(b) below, at any
time
or from time to time thereafter, the Company will have the option to redeem
all
or any outstanding shares of Preferred Stock, out of funds legally available
for
such payment, upon not less than 30 nor more than 60 days’ prior notice (the
“Redemption Notice”), in cash at a redemption price of $15.75 per share of
Preferred Stock, plus an amount in cash equal to all accrued and unpaid or
accumulated dividends from, and including, the immediately preceding Dividend
Payment Date to, but excluding, the redemption date.
In
the
event of a partial redemption of the Preferred Stock, the shares to be redeemed
will be selected on a pro rata basis, except that the Company may redeem
all
shares of Preferred Stock held by any holder of fewer than 100 shares (or
all
shares of Preferred Stock owned by any holder who would hold fewer than 100
shares as a result of such redemption), as determined by the Board of Directors
or a duly authorized committee thereof.
-2-
(b) Notwithstanding
Section 5(a) above, the Company may not redeem all or any outstanding shares
of
Preferred Stock on or after the fifth anniversary of the Issue Date and prior
to
the eighth anniversary of the Issue Date, unless the average Sale Price of
the
Common Stock for the 20 Trading Days ending on the Trading Day prior to the
date
the Company gives notice of such redemption pursuant to this Section 5 equals
or
exceeds the Conversion Price in effect on such Trading Day. For the avoidance
of
doubt, this Section 5(b) shall not apply to any Company redemption of
outstanding shares of Preferred Stock on or after the eighth anniversary
of the
Issue Date.
(c) In
the
case of any redemption pursuant to Section 5(a):
(i) Payment
of
the redemption price for Preferred Stock is conditioned upon book-entry transfer
of or physical delivery of the certificates representing the Preferred Stock,
together with necessary endorsements, to the Registrar at any time after
delivery of the Redemption Notice. Payment of the redemption price for the
Preferred Stock will be made promptly following the later of the redemption
date
and book-entry transfer of or physical delivery of the certificates representing
the Preferred Stock, together with necessary endorsements, to the
Registrar.
(ii) If
DTC and
the Registrar hold for such purpose money sufficient to pay the redemption
price
of Preferred Stock on the redemption date for shares of Preferred Stock
delivered for redemption in accordance with the terms of this Certificate,
then
the dividends will cease to accrue. At such time, all rights of a holder
as a
holder of Preferred Stock shall terminate, other than the right to receive
the
redemption price upon book-entry transfer of or physical delivery of the
certificates representing the Preferred Stock, together with necessary
endorsements.
SECTION
6. Voting
Rights.
(a) Holders
of
Preferred Stock will not have any voting rights except as from time to time
required under the General Corporation Law of the State of Delaware and as
set
forth in this Section 6 and Section 14 hereto. The holder of each share of
Preferred Stock shall have the right to one vote for each share of Common
Stock
into which such share of Preferred Stock could then be converted (with any
fractional share, determined on an aggregate conversion basis, being rounded
to
the nearest whole share) and, with respect to such vote, such holder shall
have
full voting rights and powers equal to the voting rights and powers of the
holders of shares of Common Stock, and shall be entitled to notice of any
stockholders’ meeting in accordance with the Bylaws of the Company, and, except
as provided in this Section 6 and Section 14 hereto, shall be entitled to
vote,
together with holders of shares of Common Stock, as a single class with respect
to any question or matter upon which holders of shares of Common Stock have
the
right to vote.
(b) If
and
whenever six full quarterly dividends, whether or not consecutive, payable
on
the Preferred Stock are not paid, the number of directors constituting the
Board
of Directors will be increased by two and the holders of Preferred Stock,
voting
together as a single class, will be entitled to elect those additional
directors. In the event of such a non-payment, any holder of Preferred Stock
may
request that the Company call a special meeting of the holders of Preferred
Stock for the purpose of electing the additional directors, and the Company
must
call such meeting within twenty (20) days of request. If the Company fails
to
call such a meeting upon request, then any holder of Preferred Stock can
call
such a meeting. If all accumulated dividends on the Preferred Stock have
been
paid in full and dividends for the current quarterly dividend period have
been
paid, the holders of Preferred Stock will no longer have the right to vote
on
directors and the term of office of each director so elected will terminate
and
the number of members of the Board of Directors will, without further action,
be
reduced by two. The voting rights provided in this Section 6(b) represent
the
sole remedy available to the holders of Preferred Stock for the Company’s
failure to pay dividends on Preferred Stock.
(c) In
any
case where the holders of Preferred Stock are entitled to vote as a class
under
this Section 6 or Section 14 hereto, each holder of Preferred Stock will
be
entitled to one vote for each share of Preferred Stock owned by such
holder.
-3-
SECTION
7. Conversion
Rights.
(a) Each
share
of Preferred Stock shall be convertible at the option of the holder thereof,
unless previously redeemed, into fully paid and nonassessable shares of Common
Stock at an initial conversion price of $65.07 per share, adjusted as described
below in Section 8 (the “Conversion
Price”).
The
number of shares of Common Stock deliverable upon conversion of a share of
Preferred Stock (the “Conversion
Rate”)
will be
initially 0.24204, which represents the Liquidation Preference divided by
the
initial Conversion Price. The Conversion Rate will be adjusted as a result
of
any adjustment to the Conversion Price.
(b) A
holder
of shares of Preferred Stock may convert any or all of those shares by
surrendering to the Company at its principal office or at the office of the
Registrar, as may be designated by the Board of Directors, the certificate
or
certificates for those shares of Preferred Stock accompanied by a written
notice
stating that the holder elects to convert all or a specified whole number
of
those shares in accordance with this Section 7 and specifying the name or
names in which the holder wishes the certificate or certificates for shares
of
Common Stock to be issued. In case the notice specifies a name or names other
than that of the holder, the notice must be accompanied by payment of all
transfer taxes payable upon the issuance of shares of Common Stock in that
name
or names. Other than those taxes, the Company shall pay any documentary,
stamp
or similar issue or transfer taxes that may be payable in respect of any
issuance or delivery of shares of Common Stock upon conversion of shares
of
Preferred Stock. As promptly as practicable after the surrender of that
certificate or certificates and the receipt of the notice relating to the
conversion and payment of all required transfer taxes, if any, or the
demonstration to the Company’s satisfaction that those taxes have been paid, the
Company will deliver or cause to be delivered (i) certificates representing
the
number of validly issued, fully paid and nonassessable full shares of Common
Stock to which the holder, or the holder’s transferee, of shares of Preferred
Stock being converted will be entitled and (ii) if less than the full
number of shares of Preferred Stock evidenced by the surrendered certificate
or
certificates is being converted, a new certificate or certificates, of like
tenor, for the number of shares evidenced by the surrendered certificate
or
certificates less the number of shares being converted. Such conversion will
be
deemed to have been made at the close of business on the date of giving the
notice and of surrendering the certificate or certificates representing the
shares of Preferred Stock to be converted so that the rights of the holder
thereof as to the shares being converted will cease except for the right
to
receive shares of Common Stock and accrued and unpaid dividends with respect
to
the shares of Preferred Stock being converted, and the person entitled to
receive the shares of Common Stock will be treated for all purposes as having
become the record holder of those shares of Common Stock at such time. If
any
conversion under this Section 7 would result in the issuance of a fractional
share of Common Stock, the Company at its option and in its sole and absolute
discretion may either issue such fractional share or pay the holder the value
of
such fractional share.
(c) If
a
holder of shares of Preferred Stock exercises such holder’s conversion rights,
upon delivery of the shares for conversion, those shares will cease to accrue
dividends as of the end of the day immediately preceding the date of conversion.
Holders of shares of Preferred Stock who convert their shares into Common
Stock
will not be entitled to, nor will the Conversion Price or Conversion Rate
be
adjusted for, any accrued and unpaid or accumulated dividends. Notwithstanding
the prior sentence, if shares of Preferred Stock are converted into Common
Stock
during the period between the close of business on any Dividend Record Date
and
the opening of business on the corresponding Dividend Payment Date, holders
of
such shares of Preferred Stock at the close of business on the Dividend Record
Date will receive dividends declared and payable on such shares, if any,
on such
Dividend Payment Date. Such shares of Preferred Stock surrendered for conversion
must be accompanied by funds equal to the dividend declared and payable on
such
shares, if any, on such Dividend Payment Date.
(d) In
case
any shares of Preferred Stock are to be redeemed, the right of conversion
shall
cease and terminate, as to the shares of Preferred Stock to be redeemed,
at the
close of business on the Business Day immediately preceding the date fixed
for
redemption, unless the Company shall default in the payment of the redemption
price of those shares.
(e) The
Company shall at all times reserve and keep available, free from preemptive
rights, for issuance upon the conversion of shares of Preferred Stock a number
of its authorized but unissued shares of Common Stock that will from time
to
time be sufficient if necessary to permit the conversion of all Outstanding
shares of Preferred Stock. Prior to the delivery of any securities that the
Company shall be obligated to deliver upon conversion
-4-
of
the
Preferred Stock, the Company shall comply with all applicable federal and
state
laws and regulations which require action to be taken by the Company. All
shares
of Common Stock delivered upon conversion of the Preferred Stock will upon
delivery be duly and validly issued and fully paid and nonassessable, free
of
all liens and charges and not subject to any preemptive rights. The Company
shall use its reasonable best efforts to maintain at all times until the
date on
which no Preferred Stock is Outstanding the listing and trading of the Common
Stock and Preferred Stock on a United States national securities
exchange.
(f) Conversion
at Our Option Under Certain Circumstances.
If fewer
than 5% of the aggregate number of shares of Preferred Stock issued on the
Issue
Date remain outstanding, the Company may, at any time on or after the third
anniversary of the Issue Date at its option, cause all, but not less than
all,
of such Preferred Stock to be automatically converted (a “Company
Conversion”)
into
that number of shares of Common Stock equal to the Liquidation Preference
thereof plus all accrued and unpaid or accumulated dividends divided by the
lesser of (i) the Conversion Price, and (ii) the Market Price of the
Common Stock. The Company will notify each of the holders of Preferred Stock
by
mail of such a Company Conversion. Such notice shall specify the date of
such
Company Conversion which will not be less than 30 days nor more than 60 days
after the date of such notice.
SECTION
8. Adjustments
to the Conversion Price.
(a) The
Conversion Price shall be subject to adjustment from time to time as follows:
(i) Stock
Splits and Combinations.
In case
the Company shall, at any time or from time to time after the Issue Date,
(A)
subdivide or split the outstanding shares of Common Stock, (B) combine or
reclassify the outstanding shares of Common Stock into a smaller number of
shares or (C) issue by reclassification of the shares of Common Stock any
shares
of Capital Stock of the Company, then, and in each such case, the Conversion
Price in effect immediately prior to that event or the record date therefor,
whichever is earlier, shall be adjusted so that the holder of any shares
of
Preferred Stock thereafter surrendered for conversion shall be entitled to
receive the number of shares of Common Stock or other securities of the Company
which the holder would have owned or have been entitled to receive after
the
occurrence of any of the events described above, had those shares of Preferred
Stock been surrendered for conversion immediately prior to the occurrence
of
that event or the record date therefor, whichever is earlier.
(ii) Stock
Dividends in Common Stock.
In case
the Company shall, at any time or from time to time after the Issue Date,
pay a
dividend or make a distribution in shares of Common Stock to all of the holders
of the Common Stock other than dividends or distributions of shares of Common
Stock or other securities with respect to which adjustments are provided
in
Section 8(a)(i) above, the Conversion Price shall be adjusted by multiplying
(A)
the Conversion Price immediately prior to the record date fixed for
determination of stockholders entitled to receive the dividend or distribution,
by (B) a fraction, the numerator of which shall be the number of shares of
Common Stock outstanding at the close of business on that record date and
the
denominator of which shall be the sum of that number of shares and the total
number of shares of Common Stock issued in that dividend or
distribution.
(iii) Fundamental
Changes.
In case
any transaction or event (including, without limitation, any merger,
consolidation, combination, sale of assets, tender or exchange offer,
reclassification, compulsory share exchange or liquidation) shall occur in
which
all or substantially all outstanding shares of Common Stock are converted
into
or exchanged or acquired for or constitute the right to receive stock, other
securities, cash, property or assets (each, a “Fundamental
Change”),
the
holder of each share of Preferred Stock Outstanding immediately prior to
the
occurrence of such Fundamental Change that remains Outstanding after such
Fundamental Change shall have the right upon any subsequent conversion to
receive (but only out of funds legally available, to the extent required
by
applicable law) the kind and amount of stock, other securities, cash, property
or assets that such holder would have received if that share had been converted
immediately prior to the Fundamental Change.
(b) Anything
in paragraph (a) to the contrary notwithstanding, the Company shall not be
required to give effect to any adjustment in the Conversion Price unless
and
until the net effect of one or more adjustments (each of which shall be carried
forward until counted toward adjustment), determined as above provided, shall
have
-5-
resulted
in a change of the Conversion Price by at least l%, and when the cumulative
net
effect of more than one adjustment so determined shall be to change the
Conversion Price by at least 1%, such change in the Conversion Price shall
thereupon be given effect. In the event that, at any time as a result of
the
provisions of this Section 8, the holders of shares of Preferred Stock upon
subsequent conversion shall become entitled to receive any shares of Capital
Stock of the Company other than Common Stock, the number of such other shares
so
receivable upon conversion of shares of Preferred Stock shall thereafter
be
subject to adjustment from time to time in a manner and on terms as nearly
equivalent as practicable to the provisions contained in this Section
8.
(c) There
shall be no adjustment of the Conversion Price in the case of the issuance
of
any Capital Stock of the Company in a merger, reorganization, acquisition,
reclassification, recapitalization or other similar transaction except as
provided in this Section 8.
(d) The
Company may, from time to time, reduce the Conversion Price by any amount
for
any period of time if the period is at least twenty (20) days or any longer
period required by law and if the reduction is irrevocable during the period,
but the Conversion Price may not be less than the par value of Common Stock.
(e) In
any
case in which this Section 8 requires that an adjustment as a result of any
event become effective from and after a record date, the Company may elect
to
defer until after the occurrence of that event (a) issuing to the holder of
Preferred Stock converted after that record date and before the occurrence
of
that event the additional shares of Common Stock issuable upon that conversion
over and above the shares issuable on the basis of the Conversion Price in
effect immediately before adjustment and (b) paying to that holder any
amount in cash in lieu of a fractional share of Common Stock.
(f) The
Company shall, as soon as practicable following the occurrence of an event
that
requires an adjustment in the Conversion Price, provide written notice to
the
holders of Preferred Stock of the occurrence of that event. The Company shall
deliver a statement setting forth in reasonable detail the method by which
the
adjustment to the Conversion Price was determined and setting forth the revised
Conversion Price.
(g) If
the
Company shall declare a dividend or any distribution of cash, securities
or
other property in respect of its Common Stock (other than (x) a dividend
pursuant to Section 3(a) above, (y) a quarterly dividend on shares of its
Common
Stock or (z) any event that requires an adjustment in the Conversion Price),
including without limitation any granting of rights or warrants to subscribe
for
or purchase any Capital Stock of the Company or any Subsidiary, then the
Company
shall deliver to each holder of Preferred Stock a written notice setting
forth
in reasonable detail the material terms of such dividend or distribution,
at
least twenty (20) days prior to the applicable record date on which a person
would need to hold Common Stock in order to participate in such dividend
or
distribution.
(h) The
Company’s obligations under the Certificate are subject to applicable federal
and state securities laws.
(i) The
Board
of Directors shall have the power to resolve any ambiguity or, subject to
applicable law, correct any error in this Section 8 and its action in so
doing
shall be final and conclusive.
SECTION
9. Payment
Restrictions.
If the
Company does not pay a dividend on a Dividend Payment Date, then, until all
accumulated dividends have been declared and paid or declared and set apart
for
payment:
(a) the
Company may not take any of the following actions with respect to any of
its
Junior Stock: (i) declare or pay any dividend or make any distribution of
assets
on any Junior Stock, except that the Company may pay dividends in shares
of its
Junior Stock and pay cash in lieu of fractional shares in connection with
any
such dividends or (ii) redeem, purchase or otherwise acquire any Junior Stock,
except that (x) the Company may redeem, repurchase or otherwise acquire Junior
Stock upon conversion or exchange of such Junior Stock for other Junior Stock
and pay cash in lieu of fractional shares in connection with any such conversion
or exchange and (y) the Company may make (A) repurchases of Capital Stock
deemed
to occur upon the exercise of stock options if such Capital Stock represents
a
portion of the exercise price thereof (B) and repurchases of Capital Stock
deemed to occur upon the withholding of a portion of the Capital Stock issued,
granted or awarded to one of the Company’s directors, officers or employees to
-6-
pay
for
the taxes payable by such director, officer or employee upon such issuance,
grant or award in order to satisfy, in whole or in part, withholding tax
requirements in connection with the exercise of such options, in accordance
with
the provisions of an option or rights plan or program of the Company;
(b) the
Company may not take any of the following actions with respect to any of
its
Parity Stock: (i) declare or pay any dividend or make any distribution of
assets
on any of its Parity Stock, except that the Company may pay dividends on
Parity
Stock provided that the total funds to be paid be divided among the Preferred
Stock and such Parity Stock on a pro rata basis in proportion to the aggregate
amount of dividends accrued and unpaid or accumulated thereon; or (ii) redeem,
purchase or otherwise acquire any Parity Stock, except that the Company may
redeem, purchase or otherwise acquire Parity Stock upon conversion or exchange
of such Parity Stock for Junior Stock or other Parity Stock and pay cash in lieu
of fractional shares in connection with any such conversion or exchange,
so long
as, in the case of such other Parity Stock, (x) such other Parity Stock contains
terms and conditions (including, without limitation, with respect to the
payment
of dividends, dividend rates, liquidation preferences, voting and representation
rights, payment restrictions, antidilution rights, change of control rights,
covenants, remedies and conversion and redemption rights) that are not
materially less favorable, taken as a whole, to the Company or to the holders
of
Preferred Stock than those contained in the Parity Stock that is converted
into
or exchanged for such other Parity Stock, (y) the aggregate amount of the
liquidation preference of such other Parity Stock does not exceed the aggregate
amount of the liquidation preference, plus accrued and unpaid or accumulated
dividends, of the Parity Stock that is converted into or exchanged for such
other Parity Stock and (z) the aggregate number of shares of Common Stock
issuable upon conversion, redemption or exchange of such other Parity Stock
does
not exceed the aggregate number of shares of Common Stock issuable upon
conversion, redemption or exchange of the Parity Stock that is converted
into or
exchanged for such other Parity Stock.
SECTION
10. Certain
Definitions.
As used
in this Certificate, the following terms shall have the following meanings,
unless the context otherwise requires:
“Agent
Members”
has
the
meaning set forth in Section 12(b).
“Business
Day”
means
any day other than a Saturday, Sunday, or U.S. Federal or national holiday
or
day on which the Registrar is not open for business.
“Capital
Stock”
of
any
person means any and all shares, interests, participations or other equivalents
however designated of corporate stock or other equity participations, including
partnership interests, whether general or limited, of such person and any
rights
(other than debt securities convertible or exchangeable into an equity
interest), warrants or options to acquire an equity interest in such
person.
“Common
Stock”
means
the shares of common stock, par value $0.01 per share, of the
Company.
“Conversion
Agent”
has
the
meaning set forth in Section 15(a)(ii).
“Conversion
Price”
has
the
meaning set forth in Section 7(a).
“Depository”
has
the
meaning set forth in Section 12(a).
“Dividend
Payment Date”
has
the
meaning set forth in Section 3(a).
“Dividend
Payment Record Date”
has
the
meaning set forth in Section 12(a).
“Dividend
Period”
for
any
Dividend Payment Date means the period from and including the immediately
preceding Dividend Payment Date (or if there is no immediately preceding
Dividend Payment Date, from the Issue Date) to but excluding such Dividend
Payment Date.
“DTC”
means
The Depository Trust Company.
-7-
“Fundamental
Change”
has
the
meaning set forth in Section 8(a)(iii).
“Global
Preferred Certificate”
has
the
meaning set forth in Section 12(a).
“Global
Shares Legend”
has
the
meaning set forth in Section 12(a).
“holder”
or
other
similar terms mean a person in whose name a share of Preferred Stock is
registered on the Preferred Stock register.
“Issue
Date”
means
the
date
of effectiveness of the Merger.
“Junior
Stock”
means
the Common Stock and each class or series of the Company’s Capital Stock
established hereafter by the Board of Directors the terms of which provide
that
such class or series will rank junior to the Preferred Stock as to the payment
of dividends or distributions upon liquidation, dissolution or winding-up.
Junior Stock includes warrants, rights, calls or options exercisable for
or
convertible into Junior Stock.
“Liquidation
Preference”
means
US$15.75 per share of the Preferred Stock.
“Market
Price”
means
the average of the Sale Prices of the Common Stock for the ten (10) Trading
Day
period ending on the third Business Day prior to the date of Company Conversion
(if the third Business Day prior to such date is a Trading Day or, if not,
then
on the last Trading Day prior to the third Business Day).
“Officer”
means
the Chairman of the Board of Directors, the President, any Vice President,
a
Treasurer, an Assistant Treasurer, the Secretary, or any Assistant
Secretary.
“Outstanding”
means,
when used with respect to Preferred Stock, as of the date of determination,
all
shares of Preferred Stock issued pursuant to this Certificate, except (a)
Preferred Stock that has been converted into Common Stock in accordance with
Section 7 and Preferred Stock that has been canceled by the Registrar or
delivered to the Registrar for cancellation upon purchase or other acquisition
thereof by the Company; and (b) Preferred Stock for which payment or redemption
money in the necessary amount has been deposited with the Registrar or any
Paying Agent (other than the Company) in trust or set aside and segregated
in
trust by the Company (if the Company shall act as its own Paying Agent) for
the
holders of such Preferred Stock; provided
that, if
such Preferred Stock is to be redeemed, notice of such redemption has been
duly
given pursuant to this Certificate or provision therefor satisfactory to
the
Registrar has been made; provided,
however,
that, in
determining whether the holders of Preferred Stock have given any request,
demand, authorization, direction, notice, consent or waiver or taken any
other
action hereunder, Preferred Stock owned by the Company or any of its
Subsidiaries shall be deemed not to be Outstanding, except that, in determining
whether the Registrar shall be protected in relying upon any such request,
demand, authorization, direction, notice, consent, waiver or other action,
only
Preferred Stock which the Registrar has actual knowledge of being so owned
shall
be deemed not to be Outstanding.
“Parity
Stock”
means
each class or series of the Company’s Capital Stock established hereafter by the
Board of Directors the terms of which provide that such class or series will
rank on a parity with the Preferred Stock as to the payment of dividends
or
distributions upon liquidation, winding up and dissolution. Parity Stock
includes warrants, rights, calls or options exercisable for or convertible
into
Parity Stock.
“Paying
Agent”
has
the
meaning set forth in Section 15(a)(i).
“Redemption
Notice”
has
the
meaning set forth in Section 5(a).
“Registrar”
means
Computershare Trust Company, N.A., as the Company’s initial registrar, and
thereafter, any successor registrar and Registrar duly appointed by the
Company.
“Sale
Price”
of
the
Common Stock on any Trading Day means the closing sale price per share (or
if no
closing sale price is reported, the average of the bid and ask prices or,
if
more than one in either case, the average of
-8-
the
average bid and the average ask prices) on such Trading Day as reported in
composite transactions for the principal United States national securities
exchange on which the Common Stock is then listed and traded.
“Securities
Act”
means
the Securities Act of 1933, as amended.
“Securities
Exchange Act”
means
the Securities Exchange Act of 1934, as amended.
“Senior
Stock”
means
each class or series of the Company’s Capital Stock established hereafter by the
Board of Directors the terms of which expressly provide that such class or
series will rank senior to the Preferred Stock with respect to the payment
of
dividends and distributions upon liquidation, winding-up or dissolution.
Senior
Stock includes warrants, rights, calls or options exercisable for or convertible
into Senior Stock.
“Subsidiary”
means,
with respect to any person, (a) any corporation, association or other business
entity of which more than 50% of the total voting power of shares of Capital
Stock entitled (without regard to the occurrence of any contingency) to vote
in
the election of directors, managers or trustees thereof is at the time owned
or
controlled, directly or indirectly, by such person or one or more of the
other
Subsidiaries of that person (or a combination thereof) and (b) any partnership
(i) the sole general partner or the managing general partner of which is
such
person or a Subsidiary of such person or (ii) the only general partners of
which
are such person or of one or more Subsidiaries of such person (or any
combination thereof).
“Trading
Day”
means
each day on which the securities exchange or quotation system which is used
to
determine the Sale Price is open for trading or quotation.
“Voting
Stock”
of
any
person means Capital Stock of such person which ordinarily has voting power
for
the election of directors, or persons performing similar functions, of such
person, whether at all times or only for so long as no senior class of
securities has such voting power by reason of any contingency.
SECTION
11. Currency.
All
shares of Preferred Stock shall be denominated in U.S. currency, and all
payments and distributions thereon or with respect thereto shall be made
in U.S.
currency. All references herein to “$” or “dollars” refer to U.S.
currency.
SECTION
12. Form.
(a) The
Preferred Stock shall be issued in the form of one or more permanent global
certificates in definitive, fully registered form with the global legend
(the
“Global
Shares Legend”)
set
forth on the form attached hereto as Exhibit
A
(the
“Global
Preferred Certificate”),
which
is hereby incorporated in and expressly made a part of this Certificate.
The
Global Preferred Certificate may have notations, legends or endorsements
required by law, stock exchange rules, agreements to which the Company is
subject, if any, or usage (provided
that any
such notation, legend or endorsement is in a form acceptable to the Company).
The Global Preferred Certificate shall be deposited on behalf of the holders
of
the Preferred Stock represented thereby with the Registrar, at its New York
office, as custodian for DTC or its nominee and their respective successors
(the
“Depository”),
and
registered in the name of the Depository or a nominee of the Depository,
duly
executed by the Company and countersigned and registered by the Registrar
as
hereinafter provided. The aggregate number of shares represented by each
Global
Preferred Certificate may from time to time be increased or decreased by
adjustments made on the records of the Registrar and the Depository or its
nominee as hereinafter provided.
(b) This
paragraph shall apply only to a Global Preferred Certificate deposited with
or
on behalf of the Depository. The Company shall execute and the Registrar
shall,
in accordance with this Section, countersign and deliver initially one or
more
Global Preferred Certificates that (i) shall be registered in the name of
Cede
& Co. or another nominee of the Depository and (ii) shall be delivered by
the Registrar to Cede & Co. or pursuant to instructions received from Cede
& Co. or held by the Registrar as custodian for the Depository pursuant to
an agreement between the Depository and the Registrar. Members of, or
participants in, the Depository (“Agent
Members”)
shall
have no rights under this Certificate with respect to any Global Preferred
Certificate held on their behalf by the Depository or by the Registrar as
the
custodian of the Depository or under such Global Preferred Certificate, and
the
Depository may be treated by the Company, the Registrar and any agent of
the
Company or the Registrar as the ab-
-9-
solute
owner of such Global Preferred Certificate for all purposes whatsoever.
Notwithstanding the foregoing, nothing herein shall prevent the Company,
the
Registrar or any agent of the Company or the Registrar from giving effect
to any
written certification, proxy or other authorization furnished by the Depository
or impair, as between the Depository and its Agent Members, the operation
of
customary practices of the Depository governing the exercise of the rights
of a
holder of a beneficial interest in any Global Preferred Certificate. Except
as
provided in Section 12(d), owners of beneficial interests in a Global Preferred
Certificate will not be entitled to receive physical delivery of certificated
Preferred Stock.
(c) (i)
Two
Officers shall sign the Global Preferred Certificate for the Company by manual
or facsimile signature.
(ii) If
an
Officer whose signature is on a Global Preferred Certificate no longer holds
that office at the time the Registrar countersigns the Global Preferred
Certificate, the Global Preferred Certificate shall be valid nevertheless.
(iii) A
Global
Preferred Certificate shall not be valid until an authorized signatory of
the
Registrar countersigns such Global Preferred Certificate. The signature shall
be
conclusive evidence that the Global Preferred Certificate has been
authenticated. Each Global Preferred Certificate shall be dated the date
of its
authentication.
(d) The
Preferred Stock represented by a Global Preferred Certificate is exchangeable
for certificated Preferred Stock in definitive form of like tenor as such
Preferred Stock if (i) the Depository notifies the Company that it is unwilling
or unable to continue as depositary for the global securities and/or if at
any
time the Depository ceases to be a clearing agency registered under the Exchange
Act and, in each case, a successor depositary is not appointed by the Company
within 90 days after the date of such notice or (ii) the Company, in its
sole
discretion at any time determines to discontinue use of the system of book-entry
transfer through DTC (or any successor depositary). Any Preferred Stock that
is
exchangeable pursuant to the preceding sentence is exchangeable for certificated
Preferred Stock issuable in authorized denominations and registered in such
names as the Depository shall direct. Subject to the foregoing and applicable
law, a Global Preferred Certificate is not exchangeable, except for a Global
Preferred Certificate of the same aggregate Liquidation Preferences to be
registered in the name of the Depository or its nominee.
SECTION
13. Transfer.
Notwithstanding any provision to the contrary herein, so long as a Global
Preferred Certificate remains Outstanding and is held by or on behalf of
the
Depository, transfers of a Global Preferred Certificate, in whole or in part,
or
of any beneficial interest therein, shall only be made in accordance with
this
Section 13.
(a) Except
for
transfers or exchanges made in accordance with paragraph (b) of this Section
13,
transfers of a Global Preferred Certificate shall be limited to transfers
of
such Global Preferred Certificate in whole, but not in part, to nominees
of the
Depository or to a successor of the Depository or such successor’s
nominee.
(b) If
an
owner of a beneficial interest in a Global Preferred Certificate deposited
with
the Depository or with the Registrar as custodian for the Depository wishes
at
any time to transfer its interest in such Global Preferred Certificate to
a
person who is eligible to take delivery thereof in the form of a beneficial
interest in a Global Preferred Certificate, such owner may, subject to the
rules
and procedures of the Depository, cause the exchange of such interest for
a new
beneficial interest in the applicable Global Preferred Certificate. Upon
receipt
by the Registrar at its office in The City of New York of instructions from
the
holder directing the Registrar to transfer its interest in the applicable
Global
Preferred Certificate, such instructions to contain the name of the transferee
and appropriate account information, then the Registrar shall instruct the
Depository to reduce or cause to be reduced such Global Preferred Certificate
by
the number of shares of the beneficial interest therein to be exchanged and
to
debit or cause to be debited from the account of the person making such transfer
the beneficial interest in the Global Preferred Certificate that is being
transferred, and concurrently with such reduction and debit, the Registrar
will
instruct the Depository to increase or cause to be increased the applicable
Global Preferred Certificate by the aggregate number of shares being exchanged
and to credit or cause to be credited to the account of the transferee the
beneficial interest in the Global Preferred Certificate that is being
transferred.
-10-
SECTION
14. Amendment
of Certificate of Designations; Senior Stock and Parity Stock.
(a) The
Company may not amend this Certificate without the affirmative vote or consent
of the holders of a majority of the shares of Preferred Stock then Outstanding
(including votes or consents obtained in connection with a tender offer or
exchange offer for the Preferred Stock), voting as a class, and, except as
otherwise provided by applicable law, any past default or failure to comply
with
any provision of this Certificate may not be waived without the consent of
such
holders, voting as a class. Notwithstanding the foregoing, however, without
the
consent of each holder affected, an amendment or waiver may not (with respect
to
any shares of the Preferred Stock held by a non-consenting holder): (i) alter
the voting rights with respect to the Preferred Stock or reduce the number
of
shares of the Preferred Stock whose holders must consent to an amendment,
supplement or waiver, (ii) reduce the Liquidation Preference of any share
of the
Preferred Stock or materially adversely alter the provisions with respect
to the
redemption of the Preferred Stock, (iii) reduce the rate of or change the
time
for payment of dividends on any share of the Preferred Stock, (iv) waive
a
default in the payment of dividends on the Preferred Stock, (v) make any
share
of the Preferred Stock payable in money other than United States dollars,
(vi)
make any changes in the provisions of this Certificate relating to waivers
of
the rights of holders to receive the Liquidation Preference or dividends
on the
Preferred Stock, or (vii) make any change in the foregoing amendment and
waiver
provisions.
Notwithstanding
the foregoing, without the consent of any holder, the Company may (to the
extent
permitted by, and subject to the requirements of, Delaware law) amend or
supplement this Certificate to cure any ambiguity, defect or inconsistency,
to
provide for uncertificated shares of the Preferred Stock in addition to or
in
place of certificated shares of the Preferred Stock, to make any change that
would provide any additional rights or benefits to the holders or to make
any
change that the Board of Directors determines, in good faith, is not materially
adverse to holders of the Preferred Stock.
(b) So
long as
any shares of the Preferred Stock remain Outstanding, the Company shall not,
without the affirmative vote of the holders of at least two-thirds of the
shares
of Preferred Stock Outstanding at the time, voting as a class, (i) issue
shares of or increase the authorized number of shares of any Senior Stock
or
Parity Stock or (ii) amend the Company’s Certificate of Incorporation or
the resolutions contained in this Certificate, whether by merger, consolidation
or otherwise, if the amendment would alter or change any power, preference
or
special right of the Outstanding Preferred Stock in any manner materially
adverse to the interests of the holders thereof. Notwithstanding the foregoing,
neither (x) an increase in the authorized number of shares of Common Stock
or the authorization and issuance of Junior Stock, including that with voting
or
redemption rights that are different from the voting or redemption rights
of the
Preferred Stock, nor (y) an increase, decrease or change in the par value
of any class or series of Capital Stock, including the Preferred Stock, shall
be
deemed to be an amendment that alters or changes such powers, preferences
or
special rights in any manner materially adverse to the interests of the holders
of Preferred Stock.
SECTION
15. Paying
Agent and Conversion Agent.
(a) The
Company shall maintain in the City of Canton, State of Georgia, or in such
other
City and State as the Company may from time to time designate, (i) an office
or
agency where payments may be made with respect to the Preferred Stock (the
“Paying
Agent”)
and
(ii) an office or agency where Preferred Stock may be presented for conversion
(the “Conversion
Agent”).
The
Company may appoint the Registrar, the Paying Agent and the Conversion Agent
and
may appoint one or more additional paying agents and one or more additional
conversion agents in such other locations as it shall determine. The term
“Paying
Agent”
includes
any additional paying agent and the term “Conversion
Agent”
includes
any additional conversion agent. The Company may change any Paying Agent
or
Conversion Agent without prior notice to any holder. The Company shall notify
the Registrar of the name and address of any Paying Agent or Conversion Agent
appointed by the Company. If the Company fails to appoint or maintain another
entity as Paying Agent or Conversion Agent, the Registrar shall act as such.
The
Company or any of its affiliates may act as Paying Agent, Registrar,
co-Registrar or Conversion Agent.
(b) Neither
the Company nor the Registrar shall be required (i) to issue, countersign
or
register the transfer of or exchange of any Preferred Stock during a period
beginning at the opening of business 15 days before the date of the mailing
of a
notice of redemption of Preferred Stock under Section 5 and ending at the
close
of busi-
-11-
ness
on
the date of such mailing or (ii) to register the transfer of or exchange
of any
Preferred Stock so selected for redemption in whole or in part, except the
unredeemed portion of any Preferred Stock being redeemed in part.
(c) Payments
made with respect to the Preferred Stock shall be payable at the office or
agency of the Company maintained for such purpose in the City of Canton,
State
of Georgia, or in such other City and State as the Company may from time
to time
designate. Payments shall be payable by United States dollar check drawn
on, or
wire transfer (provided,
that
appropriate wire instructions have been received by the Paying Agent or
Registrar at least 15 days prior to the applicable date of payment) to a
U.S.
dollar account maintained by the holder with, a bank located in New York
City;
provided
that at
the option of the Company, payment of dividends may be made by check mailed
to
the address of the person entitled thereto as such address shall appear in
the
Preferred Stock register.
(d) Any
payment, redemption, conversion or exchange with respect to the Preferred
Stock
due on any date that is not a Business Day need not be made on such Business
Day, but may be made on the next succeeding Business Day with the same force
and
effect as if made on such due date.
SECTION
16. General.
(a) The
headings of the Sections of this Certificate are for convenience of reference
only and shall not define, limit or affect any of the provisions
hereof.
(b) Procedures
for conversion of shares of Preferred Stock, in accordance with Section 7,
not
held in certificated form will be governed by arrangements among the depositary
of the shares of Preferred Stock, its participants and persons that may hold
beneficial interests through such participants designed to permit settlement
without the physical movement of certificates. Payments, transfers, deliveries,
exchanges and other matters relating to beneficial interests in global security
certificates may be subject to various policies and procedures adopted by
the
depositary from time to time.
(c) Holders
of
the Preferred Stock are not entitled to any preemptive or subscription rights
in
respect of any securities of the Company.
(d) Whenever
possible, each provision hereof shall be interpreted in a manner as to be
effective and valid under applicable law, but if any provision hereof is
held to
be prohibited by or invalid under applicable law, such provision shall be
ineffective only to the extent of such prohibition or invalidity, without
invalidating or otherwise adversely affecting the remaining provisions hereof.
If a court of competent jurisdiction should determine that a provision hereof
would be valid or enforceable if a period of time were extended or shortened
or
a particular percentage were increased or decreased, then such court may
make
such change as shall be necessary to render the provision in question effective
and valid under applicable law.
(e) Subject
to
applicable escheat laws, any monies set aside by the Company in respect of
any
payment with respect to shares of the Preferred Stock, or dividends thereon,
and
unclaimed at the end of two years from the date upon which such payment is
due
and payable shall revert to the general funds of the Company, after which
reversion the holders of such shares shall look only to the general funds
of the
Company for the payment thereof. Any interest accrued on funds so deposited
shall be paid to the Company from time to time.
-12-
IN
WITNESS
WHEREOF, the Company has caused this Certificate of Designations to be duly
executed by
[ ],
[ ] of the Company, as of this [ ] day of
[ ],
2007.
NATIONAL
HEALTHCARE CORPORATION
By:
____________________________________
Name:
Title:
-13-
EXHIBIT
A
FACE
OF
SECURITY
UNLESS
THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY
TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE
COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND
ANY
CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER
NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT
IS
MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE
OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER
HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.
TRANSFERS
OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN
PART,
TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE
AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS
MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE CERTIFICATE OF
DESIGNATIONS REFERRED TO ON THE REVERSE HEREOF.
A-1
Number:
[
]
[ ]
Shares
CUSIP
NO.: [ ]
ISIN: [ ]
SERIES
A CONVERTIBLE PREFERRED STOCK
OF
NATIONAL
HEALTHCARE CORPORATION
NATIONAL
HEALTHCARE CORPORATION, a Delaware corporation (the “Company”),
hereby
certifies that [HOLDER] (the “Holder”)
is the
registered owner of fully paid and non-assessable shares of preferred stock
of
the Company designated as the Series A Convertible Preferred Stock, par value
$0.01 per share and liquidation preference $15.75 per share (the “Preferred
Stock”).
The
shares of Preferred Stock are transferable on the books and records of the
Registrar, in person or by a duly authorized attorney, upon surrender of
this
certificate duly endorsed and in proper form for transfer. The designation,
rights, privileges, restrictions, preferences and other terms and provisions
of
the Preferred Stock represented hereby are issued and shall in all respects
be
subject to the provisions of the Certificate of Designations of the Company
dated [ ], 2007, as the same may be amended from time to time in accordance
with
its terms (the “Certificate
of Designations”).
Capitalized terms used herein but not defined shall have the respective meanings
given them in the Certificate of Designations. The Company will provide a
copy
of the Certificate of Designations to the Holder without charge upon written
request to the Company at its principal place of business.
Reference
is hereby made to select provisions of the Preferred Stock set forth on the
reverse hereof, and to the Certificate of Designations, which select provisions
and the Certificate of Designations shall for all purposes have the same
effect
as if set forth in this certificate.
Upon
receipt of this certificate, the Holder is bound by the Certificate of
Designations and is entitled to the benefits thereunder. Unless the Registrar’s
valid countersignature appears hereon, the shares of Preferred Stock evidenced
hereby shall not be entitled to any benefit under the Certificate of
Designations or be valid or obligatory for any purpose.
A-2
IN
WITNESS
WHEREOF, the Company has executed this Preferred Stock certificate as of
the
date set forth below.
NATIONAL
HEALTHCARE CORPORATION
By:
__________________________________________
Name:
Title:
By:
__________________________________________
Name:
Title:
Dated:
________________________________________
COUNTERSIGNED
AND REGISTERED
[
],
as
Registrar
By:
_________________________________________
Authorized
Signatory
Dated:
______________________________________
A-3
REVERSE
OF SECURITY
NATIONAL
HEALTHCARECORPORATION
Series
A
Convertible Preferred Stock
Dividends
on each share of Preferred Stock shall be payable in cash at the rate of
$0.80
per annum.
The
shares
of Preferred Stock shall be redeemable as provided in the Certificate of
Designations. The shares of Preferred Stock shall be convertible into the
Company’s common stock in the manner and according to the terms set forth in the
Certificate of Designations. The Company shall furnish to any holder upon
request and without charge, a statement of the powers, designations, preferences
and relative, participating, optional or other special rights of each class
of
the Company’s Capital Stock or any series thereof and the qualifications,
limitations or restrictions of such preferences and/or rights.
A-4
ASSIGNMENT
FOR
VALUE
RECEIVED, the undersigned assigns and transfers the shares of Preferred Stock
evidenced hereby to:
and
irrevocably appoints:
Date:
________________________________________________________________________________________________________________________
Signature:
_____________________________________________________________________________________________________________________
(Sign
exactly as your name appears on the other side of this Preferred Stock
Certificate)
Signature
Guarantee:
*
|
Signature
must be guaranteed by an “eligible guarantor institution”
(i.e., a bank, stockbroker, savings and loan association or credit union) meeting the requirements of the Registrar, which requirements include membership or participation in the Securities Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. |
A-5
NOTICE
OF CONVERSION
(To
Be
Executed by the Registered Holder
in
Order
to Convert the Preferred Stock)
The
undersigned hereby irrevocably elects to convert (the “Conversion”)
[ ]
shares of Series A Convertible Preferred Stock (the “Preferred
Stock”)
into
shares of common stock, par value $0.01 per share (“Common
Stock”),
of
National HealthCare Corporation (the “Company”)
according to the conditions of the Certificate of Designations establishing
the
terms of the Preferred Stock (the “Certificate
of Designations”),
as of
the date written below. If shares are to be issued in the name of a person
other
than the undersigned, the undersigned will pay all transfer taxes payable
with
respect thereto and is delivering herewith such certificates. No fee will
be
charged to the holder for any conversion, except for transfer taxes, if any.
A
copy of each stock certificate representing the shares to be converted is
attached hereto (or evidence of loss, theft or destruction
thereof).*
Capitalized
terms used but not defined herein shall have the meanings ascribed thereto
in or
pursuant to the Certificate of Designations.
Date
of
Conversion:____________________________________________________________________________________________________________
Applicable
Conversion
Price:_____________________________________________________________________________________________________
Number
of
shares of Preferred Stock to be
Converted:__________________________________________________________________________________
Number
of
shares of Common Stock to be
Issued:_____________________________________________________________________________________
Signature:_____________________________________________________________________________________________________________________
(Sign
exactly as your name appears on the other side of this Preferred Stock
Certificate)
Signature
Guarantee:
*
|
Signature
must be guaranteed by an “eligible guarantor institution”
(i.e., a bank, stockbroker, savings and loan association or credit union) meeting the requirements of the Registrar, which requirements include membership or participation in the Securities Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. |
Name:________________________________________________________________________________________________________________________
Address:**____________________________________________________________________________________________________________________
Fax
No.:______________________________________________________________________________________________________________________
* The
Company is not required to issue shares of Common Stock to a person holding
Preferred Stock until evidence of the book-entry transfer of, or physical
delivery of the stock certificates representing such Preferred Stock to be
converted (or evidence of loss, theft or destruction thereof) are received
by
the Company or its Registrar.
** Address
where certificated shares of Common Stock, if any, and any other payments
or
certificates shall be sent by the Company.
A-6
Global
Share Schedule: (include if Security is issued as a global certificate)
SCHEDULE
A
SCHEDULE
OF EXCHANGES FOR GLOBAL SECURITY
The
initial number of shares of Preferred Stock represented by this Global Preferred
Certificate shall be
[ ]. The
following exchanges of a part of this Global Preferred Certificate have been
made:
Date
of
Exchange
|
Amount
of decrease
in
number of shares represented by this Global Preferred
Certificate
|
Amount
of increase
in
number of shares represented by this Global Preferred
Certificate
|
Number
of shares
represented
by this Global Preferred Certificate following such decrease
or increase
|
Signature
of
authorized
officer
of
Registrar
|
A-7
Form
of
Affiliate Letter
Ladies
and
Gentlemen:
The
undersigned refers to the Agreement and Plan of Merger (the “Merger
Agreement”),
dated
as of December 20, 2006, by and among Xxxxx Acquisition Sub LLC a Delaware
limited liability company (“NHC/OP
Sub”),
NHC/OP, L.P., a Delaware limited partnership and the direct parent of NHC/OP
Sub
(“NHC/OP”),
National HealthCare Corporation, a Delaware corporation and the ultimate
parent
of NHC/OP (“Parent”),
and
National Health Realty, Inc., a Maryland corporation (the “Company”).
Capitalized terms used but not defined in this letter have the meanings given
such terms in the Merger Agreement.
The
undersigned, a holder of shares of Company Common Stock, is entitled to receive
in connection with the Merger shares of Parent’s Series A Convertible
Preferred Stock, par value $0.01 per share (the “Parent
Preferred Stock”).
The
undersigned acknowledges that the undersigned may be deemed an “affiliate” of
the Company within the meaning of Rule 145 (“Rule
145”)
promulgated under the Securities Act, although nothing contained herein should
be construed as an admission of such fact.
If
in fact
the undersigned were an affiliate under the Securities Act, the undersigned’s
ability to sell, assign or transfer the Parent Preferred Stock received by
the
undersigned in exchange for any shares of Company Common Stock pursuant to
the
Merger may be restricted unless such sale, assignment or transfer is registered
under the Securities Act or an exemption from such registration is available.
The undersigned (i) understands that such exemptions are limited and
(ii) has obtained advice of counsel as to the nature and conditions of such
exemptions, including information with respect to the applicability to the
sale
of such securities of Rules 144 and 145(d) promulgated under the Securities
Act.
The undersigned understands that Parent will not be required to maintain
the
effectiveness of any registration statement under the Securities Act for
purposes of resale of Parent Preferred Stock by the undersigned.
The
undersigned hereby represents to and covenants with Parent that the undersigned
will not sell, assign or transfer any of the Parent Preferred Stock received
by
the undersigned in exchange for shares of Company Common Stock pursuant to
the
Merger except (i) pursuant to an effective registration statement under the
Securities Act, (ii) in conformity with the volume and other limitations of
Rule 144 or (iii) in a transaction that, in the opinion of counsel to
Parent or other counsel reasonably satisfactory to Parent or as described
in a
“no-action” or interpretive letter from the staff of the SEC specifically issued
with respect to a transaction to be engaged in by the undersigned, is not
required to be registered under the Securities Act.
In
the
event of a sale or other disposition by the undersigned pursuant to Rule
145(d)
of Parent Preferred Stock, the undersigned will supply Parent with evidence
of
compliance with such Rule, in the form of a letter in the form of Annex
I
hereto
and the opinion of counsel or no-action letter referred to above. The
undersigned understands that Parent may instruct its transfer agent to withhold
the transfer of any Parent Preferred Stock disposed of by the
undersigned,
but that upon receipt of such evidence of compliance Parent shall cause the
transfer agent to effectuate the transfer of the Parent Preferred Stock sold
as
indicated in the letter.
The
undersigned acknowledges and agrees that the legend set forth below will
be
placed on certificates representing Parent Preferred Stock received by the
undersigned in connection with the Merger or held by a transferee thereof,
which
legend will be removed by delivery of substitute certificates upon receipt
of an
opinion in form and substance reasonably satisfactory to Parent from independent
counsel reasonably satisfactory to Parent to the effect that such legend
is no
longer required for purposes of the Securities Act.
“THE
SHARES REPRESENTED BY THIS CERTIFICATE WERE ISSUED IN A TRANSACTION TO WHICH
RULE 145 PROMULGATED UNDER THE SECURITIES ACT OF 1933 APPLIES. THE SHARES
HAVE
NOT BEEN ACQUIRED BY THE HOLDER WITH A VIEW TO, OR FOR RESALE IN CONNECTION
WITH, ANY DISTRIBUTION THEREOF WITHIN THE MEANING OF THE SECURITIES ACT OF
1933.
THE SHARES MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN
ACCORDANCE WITH AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT OF 1933.”
The
undersigned acknowledges that (i) the undersigned has carefully read this
letter and understands the requirements hereof and the limitations imposed
upon
the distribution, sale, transfer or other disposition of Parent Preferred
Stock
and (ii) the receipt by Parent of this letter is an inducement and a
condition to Parent’s obligations to consummate the Merger.
This
Agreement shall only become effective as of the Effective Time of the
Merger.
Very
truly
yours,
Dated:
[ ]
ANNEX
I
[Name]
On
[ ], the
undersigned sold the securities of National HealthCare Corporation
(“NHC”)
described below in the space provided for that purpose (the “Securities”).
The
Securities were received by the undersigned in connection with the merger
of
National Health Realty, Inc., a Maryland corporation, with and into Xxxxx
Acquisition Sub LLC, a Delaware limited liability company and an indirect
wholly-owned subsidiary of NHC.
Based
upon
the most recent report or statement filed by NHC with the Securities and
Exchange Commission, the Securities sold by the undersigned were within the
prescribed limitations set forth in paragraph (e) of Rule 144 promulgated
under
the Securities Act of 1933, as amended (the “Securities
Act”).
The
undersigned represents that the Securities were sold in “brokers transactions,”
within the meaning of Section 4(4) of the Securities Act, or in transactions
with a “market maker,” as that term is defined in Section 3(a)(38) of the
Securities Exchange Act of 1934, as amended. The undersigned further represents
that the undersigned has not solicited or arranged for the solicitation of
orders to buy the Securities, and that the undersigned has not made any payment
in connection with the offer or sale of the Securities to any person other
than
to the broker who executed the order in respect of such sale.
Very
truly
yours,
[Space
to be provided for description of the Securities]
-2-